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1. Introduction 
 
 
1.1 The acute respiratory distress syndrome 
 
The acute respiratory distress syndrome (ARDS) has an incidence of up to 75 per 
100,000 individuals; in the United States of America, more than 150,000 cases 
are registered annually, and ARDS displays mortality rates of above 30 % 
(Zilberberg and Epstein 1998; ARDSNet 2000). Typical characteristics of ARDS 
include increased endothelial permeability (Kollef and Schuster 1995) and 
impaired epithelial barrier function (Matthay and Wiener-Kronish 1990); 
(Sznajder 1999), resulting in the accumulation of excess interstitial and/or 
alveolar edema fluid (Figure 1). Impaired edema fluid reabsorption is also 
associated with ARDS, and is essential for the resolution of this disease (Ware 
and Matthay 2001), since clearance of edema fluid is essential in patients with 
ARDS to survive (Matthay 2002); (Sznajder 2001). The underlying causes of 
ARDS include sepsis, pneumonia, trauma, multiple transfusions or acute 
pancreatitis. To set standard definitions, an American-European Consensus 
Conference (AECC) was convened in 1992. In their report, members of the 
conference defined acute lung injury (ALI) as the acute onset of arterial 
hypoxemia (partial arterial oxygen pressure [PaO2]/fraction of inspired oxygen 
[FiO2] ratio, under 300), a pulmonary artery wedge pressure less than 18 mmHg 
or no clinical evidence of left atrial hypertension, and bilateral infiltrates 
consistent with pulmonary edema on frontal chest radiography. The authors 
specifically noted that the pulmonary infiltrates could be mild. Acute respiratory 
distress syndrome is defined by the same criteria as ALI, but with more severe 
hypoxemia (PaO2/FiO2, lower than 200). 
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Figure 1. Normal alveolar structure and function in comparison to circumstances in the 
acute phase of ALI/ARDS. 
On the left-hand side of the figure, the structure of the mammalian alveolo-capillary 
barrier in health is illustrated. The right-hand side of the figure illustrates inflammation 
and protein-rich alveolar edema formation in the alveolar space during the acute phase 
of ALI/ARDS. A depiction of cellular responses, mediators, as well as multiple 
molecular factors leading to imbalances between reparative and injurious pathways is 
illustrated. [Courtesy of Drs Ware and Matthay, reference (Ware and Matthay 2000)]. 
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1.2 Alveolar fluid balance 
 
In healthy humans, the apical side of the alveolar monolayer is covered by a thin 
fluid layer, termed the epithelial lining fluid (ELF). This fluid provides optimal 
surface tension regulation, and maintains basic host defense of the lung without 
affecting diffusion of gases. Thus, accumulation of fluid in the alveolar space 
severely impairs gas exchange. In ARDS, the excess alveolar liquid also includes 
massively increased amount of protein. Junctions of the epithelial monolayer 
become more permeable, followed by a considerable increase in the leakage of 
plasma proteins into the alveolar space. In healthy subjects the protein 
concentration in the ELF is approximately 8 – 10 % of the plasma concentration 
(Kim and Malik 2003). During edema formation in ARDS the plasma fractions in 
the ELF comprise protein levels between 40 - 90% (Hastings, Folkesson et al. 
2004) of the plasma level (40-60 g/L). In contrast, edema fluid from patients with 
hydrostatic edema (transudate) contains less plasma protein compared to edema 
fluid from patients with permeability edema (exsudate), as assessed by a ratio of 
protein concentrations of edema fluid versus plasma (< 65% and > 65%, 
respectively) (Fein, Grossman et al. 1979). Protein concentration in the distal air 
spaces increases further during the recovery phase from alveolar edema because 
salt and water are cleared much faster than albumin (Matthay, Berthiaume et al. 
1985; Matthay, Folkesson et al. 2002).  
The primary mechanism driving fluid reabsorption from the alveolar space 
is the active transport of sodium from the airspace into the lung interstitium and 
pulmonary circulation (Matthay, Folkesson et al. 2002). Sodium uptake by 
alveolar epithelial cells occurs on the apical surface of the epithelium, primarily 
through amiloride-sensitive and -insensitive Na+ channels (Matalon and 
O'Brodovich 1999; Kellenberger and Schild 2002), with subsequent transport out 
of the cell by Na+,K+-adenosine triphosphatease (Na+,K+-ATPase) located on the 
basolateral surface (Skou 1998; Sznajder, Factor et al. 2002). This active 
vectorial sodium flux generates an osmotic gradient, which leads to the 
movement of water from the alveolar space into the interstitium (Matthay, 
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Folkesson et al. 2002) and subsequently to the blood. Extensive research on 
human lungs (Sakuma, Okaniwa et al. 1994), in animal models (Serikov, Grady 
et al. 1993) and in both fluid-filled (Rutschman, Olivera et al. 1993) and 
ventilated isolated lung models (Vadasz, Morty et al. 2005) has demonstrated 
that alveolar fluid clearance is largely abrogated by hypothermia, probably by 
inhibition of active solute transport processes, and is inhibited by both amiloride, 
a specific inhibitor of some epithelial Na+ channels (ENaC), as well as the 
Na+,K+-ATPase inhibitor ouabain (Ghofrani, Kohstall et al. 2001; Matthay, 
Folkesson et al. 2002). Furthermore, it has been well established (Saldias, 
Comellas et al. 1999; Azzam, Dumasius et al. 2002) that upregulation of ENaC 
and Na+,K+-ATPase increases active transepithelial Na+ reabsorption, and thus 
the ability of the lungs to clear edema fluid (Therien and Blostein 2000; Kaplan 
2002). Thus, it has been conclusively demonstrated that vectorial transport of 
sodium, mediated by apical sodium channels and the basolateral Na+,K+-ATPase, 
is the main contributor to alveolar liquid reabsorption  
 
 
1.3 Effects of excess protein on alveolar epithelial function 
 
Mechanisms by which excess protein is cleared from the alveolar space are not 
fully understood, although it has been documented that the velocity of albumin 
transport is significantly slower than that of sodium transport. As the 
concentration of protein further increases due to the differences in the transport 
rates of sodium and proteins, the clearence of edema fluid is hampered by the 
increased oncotic pressure generated by the excess protein in the alveolar space, 
thereby impeding recovery (Hastings, Folkesson et al. 2004). This alveolar 
flooding massively restricts alveolar gas exchange, resulting in alveolar hypoxia 
and systemic hypoxemia which have additional deleterious effects on the 
alveolar epithelial function and further impairs fluid balance of the lung (Vadasz 
and Sznajder 2006). Patients with ARDS exhibit elevated levels of precipitated 
protein in their distal air spaces. In alveolar edema fluid from non-survivors of 
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ARDS, the concentration of the precipitated protein was three times higher than 
in survivors (Bachofen and Weibel 1977). It is believed that the excess protein in 
the distal air spaces may play a role in hyaline membrane formation and thereby 
the development of end-stage fibrosis (Kobashi and Manabe 1993), 
(Tomashefski 1990). Possible modifications of excess proteins and degradation 
products like cationic amino acids and peptides may also have deleterious effects 
on the alveolar epithelium or transepithelial pathways and result in further edema 
formation (Kim and Malik 2003). Thus, the inability to remove excess protein 
from the alveolar space may play a major role in the poor outcome of patients 
with ARDS.  
 
 
1.4 The anatomy of the lung 
 
The alveolus and surrounding microcirculation are the primary sites of protein 
transport in the lung. Under physiological conditions, this area is composed of an 
epithelial and endothelial monolayer, which is separated by a minute interstitial 
space. The alveolar epithelium consist of type I and type II pneumocytes, and 
while these cell types are present in the lung in similar numbers, the type I cells 
represent ~95 % of the alveolar surface area (Mutlu and Sznajder 2005). These 
epithelial cells, together with their tight junctions, represent the primary barrier 
for solutes and electrolytes; compared with the endothelial monolayer, which is 
more permeable (Taylor and Gaar 1970). 
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1.5 Mechanisms of protein clearance from the distal airways 
 
Several processes have been implicated in the mechanism that clears excess 
protein from the alveolar space. These include mucociliary clearance, 
endocytosis by alveolar macrophages, alveolar degradation with absorption of 
small molecular weight fragments by pneumocytes, and absorption across the 
alveolar and bronchial epithelium (Folkesson, Matthay et al. 1996). A schematic 
depiction of possible albumin clearance pathways is illustrated in Figure 2. 
Mucociliary protein clearance with or without metabolic breakdown could 
clear proteins from the respiratory tract by moving proteins up the bronchial tree. 
Excess protein could reach ciliated epithelial cells in the terminal bronchioles via 
currents in the ELF (Kilburn 1968), however, a long half-time for mucociliary 
clearance (several days) from the alveolar compartment probably does not 
account for protein movement out of the alveolar space, since the latter process 
was found to be several orders of magnitude faster (Berthiaume, Albertine et al. 
1989). Nevertheless, there is evidence for clearance via the mucociliary escalator, 
although with minimal - almost negligible - contribution to alveolar protein 
clearance, as assessed by detection of radio-labeled albumin or fibrinogen in the 
upper airways after intratracheal instillation (Meyer, Ottaviano et al. 1977; 
Meyer, Ottaviano et al. 1978). 
 Alveolar macrophages exhibit a larger endocytic capacity than do type II 
alveolar epithelial cells (Hastings, Folkesson et al. 1995) and their ability to 
degrade exogenous proteins and peptides (Steinman, Brodie et al. 1976) suggests 
that they may play a role in protein clearance from the alveolar compartment. 
However, clearance of proteins from the alveolar space is probably not mediated 
by alveolar macrophages, since in experiments where sheep lungs were instilled 
with autologous serum, thereby resulting in higher macrophage number in the air 
spaces, protein clearance remained unchanged (Matthay, Berthiaume et al. 1985). 
In that study, contribution of macrophages to protein clearance remained minor, 
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Figure 2. Schematic depiction of possible albumin trafficking pathways accross the 
alveolo-capillary barrier 
Multiple possible mechanisms of albumin clearance from the alveolar compartment are 
depicted. Paracellular movement of protein either to the vasculature or to the lymphatic 
system are suggested, or elimination of albumin by macrophages. Furthermore, 
movement of albumin from the distal air spaces through alveolar epithelial cells is 
shown suggesting an active uptake of the molecule. [Courtesy of Dr Folkesson and 
collegues, reference (Folkesson and Matthay 1996)]. 
 
 
(1 - 2 days) but interestingly, in longer studies (2 - 6 days) the influx of 
macrophages into the alveolar compartment increased substantially, and was 
associated with increased quantities of protein tracer accumulation in 
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macrophages (Berthiaume, Albertine et al. 1989). However, despite of this 
increase macrophages appeared to play a minor role in alveolar protein clearance 
because the quantity of 125I-albumin present in the phagocytic cells in the air 
spaces was less than 1 % of the instilled 125I-albumin at all time points 
(Berthiaume, Albertine et al. 1989). In contrast, macrophages have been reported 
to play an important role in the clearance of surfactant apoproteins, and 
surfactant protein A (Ueda, Ikegami et al. 1995). Thus, alveolar macrophages 
may be important in the movement of some proteins from the alveolar 
compartment, in particular after long time periods, but their contribution in 
albumin removal from the distal air space is probably minimal. 
Degradation of proteins in the ELF and absorption of small molecular 
weight fragments by pneumocytes could be also involved in protein clearance 
from the alveolar compartment. Thus, measurement of breakdown products in 
the alveolar space has been carried out by polyacrylamide agarose gel 
electrophoresis (Matthay, Berthiaume et al. 1985; Berthiaume, Albertine et al. 
1989), trichloroacetic acid precipitation (Berthiaume, Broaddus et al. 1988; 
Berthiaume, Albertine et al. 1989), immunoprecipitation (Folkesson, Westrom et 
al. 1990; Folkesson, Westrom et al. 1993), and chromatography (Berthiaume, 
Albertine et al. 1989). Since the main classes of proteases in the alveolar space 
are metallo and serine proteases (Gross 1995; Greenlee, Werb et al. 2007), 
inhibition of these enzymes in the ELF is a powerful tool to examine albumin 
degradation in the alveoli. In particular, ethylenediaminetetraacetic acid (EDTA), 
a chelating agent, is widely used to sequester di- and trivalent metal ions. EDTA 
features four carboxylic acid and two amine groups which bind to metals, thereby 
inhibiting metallo proteases (Chiancone, Thulin et al. 1986), while 
4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF), an irreversible inhibitor of 
serine proteases (Lunn and Sansone 1994), is often applied to block this protease 
class in the ELF. Additionally, peptidases are present in and on the apical 
membranes of pneumocytes (Nadel 1990; Ishii, Hashizume et al. 1991; 
Morimoto, Yamahara et al. 1993), thus, degradation might occurs through the 
action of proteases in the alveolus, in the cell membranes of the pneumocytes, or 
 8
after endocytosis. For example, there is evidence for degradation of the 
vasoactive intestinal polypeptide in the alveolus (Barrowcliffe, Morice et al. 
1986). In contrast, several studies have suggested that bigger proteins (such as 
serum proteins including albumin) are probably transported intact across the 
alveolo-capillary barrier, as assessed by measurements of the integrity of instilled 
radio-labeled proteins in the perfusion (Berthiaume, Albertine et al. 1989; 
Folkesson, Westrom et al. 1990; Folkesson, Westrom et al. 1992). Alternatively, 
some investigators have suggested that protein transport across the excised 
canine bronchial epithelium to be accompanied by degradation (Johnson, Cheng 
et al. 1989) when proteins were nebulized. These contradictory findings highlight 
the need for further examinations in this field of investigation. 
Under physiological conditions, the alveolo-capillary barrier is effectively 
impermeable to large solutes such as proteins, primarily due to the tight epithelial 
monolayer which exhibits a reflection coefficient for proteins of ~0.95, as 
opposed to the capillary endothelium, which is much more permeable, and has a 
reflection coefficient of ~0.7 (Gorin and Stewart 1979). In the alveoli, epithelial 
type I and type II cells are connected by a series of intercellular junctions. These 
apically-located intercellular junctions are referred to as the apical junctional 
complex which is composed of a tight junction and an adherens junction 
(Gumbiner 1987). Tight junctions are semipermeable gates regulating passive 
movement of luminal fluid and solutes through the paracellular pathway. This 
property of the tight junctions, in combination with transcellular vectorial 
transport, generates distinct environments in the opposing compartments. Thus, 
tight junctions are necessary to prevent dissipation of concentration gradients that 
exist between adjacent compartments (Laukoetter, Bruewer et al. 2006). 
Subjacent to tight junctions, adherens junctions, mainly composed of cadherins 
and catenins, are important in regulating intercellular adhesion (Mehta and Malik 
2006). Thus, paracellular movement of plasma proteins through the alveolar 
epithelial monolayer is thought to be marginal under normal conditions. 
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1.6 Mechanisms of protein uptake by the alveolar epithelium 
 
Recent studies have described an active albumin transport in various organs, 
including the proximal tubule cells of the kidney (Caruso-Neves, Kwon et al. 
2005) and in the mammary gland of lactating mice (Monks and Neville 2004). 
Furthermore, it has been well documented that the bulk of albumin is taken up by 
the endothelial cells by endocytosis (Mehta and Malik 2006). In contrast, 
mechanisms of albumin uptake by the alveolar epithelium are poorly understood, 
although it is believed to occur by an endocytic process.  
Endocytosis of macromolecules can be mediated by non-specific, fluid-
phase uptake (macropinocytosis) where the degree of internalization is directly 
proportional to the concentration of the molecule present in the medium. During 
macropinocytosis, endocytic vesicles nonspecifically internalize small droplets of 
extracellular fluid. This process is extremely slow and cannot be saturated or 
competed out by the presence of other macromolecules (Conner and Schmid 
2003). In the lung, horseradish peroxidase is taken up by alveolar epithelium by a 
fluid-phase transport, albeit at a much lower rate compared to albumin (John, 
Vogel et al. 2001; Kim and Malik 2003). In contrast, a much greater efficiency of 
endocytosis is achieved when dilute solutes are captured by specific high-affinity 
receptors (receptor-mediated endocytosis) (Conner and Schmid 2003). Up until 
now, two major receptor-mediated endocytic pathways have been described 
termed the caveolae-mediated and clathrin-dependent endocytosis. 
 
 
1.7 Caveolae-mediated endocytosis 
 
Caveolae are organelles with a diameter of 50 - 100 nm. In the endothelium, 
approximately 15 % of the total cell volume consists of caveolae, and up to 
30,000 caveolae per cell exist (Johansson 1979). Although the basic structure of 
caveolae is independent of the cell type, their function and arrangement are cell 
type-dependent. Two subsets of caveolae have been described (Pelkmans and 
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Zerial 2005). Caveolae are either stored in stationary multi-caveolar structures at 
the plasma membrane, or undergo continuous cycles of fission and fusion with 
the plasma membrane. The process of endocytosis begins with the formation of 
caveolae. The integral membrane protein, caveolin-1, is required for the 
formation of caveolae (Drab, Verkade et al. 2001). Caveolin-2, a second 
participant, is also implicated in the caveolae cycle (Das, Lewis et al. 1999) 
although this hypothesis is controversial (Razani, Wang et al. 2002). In 
particular, some chemical reactions such as phosphorylation, palmitoylation, 
application of glycosphingolipids, and contact with cellular cholesterol may lead 
to caveolin-1 oligomerisation, regulation of intracellular localization, and 
sequestration to the plasma membrane (Sharma, Brown et al. 2004). Cholesterol 
is an important modulator of caveolae function, and conserves the structural 
integrity of the vesicle; thus filipin, a cholesterol binding agent, can impair the 
function of caveolae as this agent removes cholesterol from caveolae followed by 
its disassembly (Schnitzer, Oh et al. 1994). 
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Figure 3. Schematic depiction of the signaling mechanisms that regulate caveolae-
mediated endocytosis, trafficking and exocytosis of albumin in endothelial cells. 
Albumin docking to the albumin binding protein (gp60) leads to activation of specific 
kinases. After phosphorylation of the molecular motor, dynamin, and caveolin-1, the 
phosphorylated molecules induce fission of caveolae from the membrane. The free 
vesicle moves through the cell and the SNARE machinery enables its fusion with the 
target membrane and thus exocytosis of albumin. [Courtesy of Drs Minshall and 
Tiruppathi, reference (Minshall, Tiruppathi et al. 2002)]. 
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It has been conclusively demonstrated that caveolin-1 is a key molecule in 
the caveolae-mediated endocytosis of albumin in endothelial cells (Mehta and 
Malik 2006). The caveolae-mediated apical uptake of albumin is generally 
followed by trafficking of the protein to the basolateral side of the endothelium 
and its subsequent exocytosis, collectively referred as transcytosis (Mehta and 
Malik 2006). The soluble N-ethylmaleimide-sensitive factor attachment protein 
receptor (SNARE) machinery may be required for caveolae-mediated 
transcytosis as a carrier system in the cells. The t-SNAREs are localized on the 
target (syntaxin and SNAP-25 family), whereas v-SNAREs (VAMP, vesicle-
associated membrane protein) are components of the vesicle membrane. Contact 
between these two domains leads to fusion of the vesicle and target membranes, 
resulting in the release of albumin by exocytosis (Gerst 2003). 
A key player in the regulation of exocytosis is the NEM-sensitive factor 
(NSF) (Whiteheart and Matveeva 2004). This adenosine triphosphatase (ATPase) 
initiates disassembly of v-SNARE and t-SNARE complexes. N-ethylmaleimide 
potently inhibits NSF by preventing the recycling activity of the ATPase, thereby 
inhibiting further exocytosis followed by a marked decrease of albumin 
transcytosis in cultured endothelial cells (Schnitzer, Allard et al. 1995) as well as 
in situ (Predescu, Horvat et al. 1994). However, several other molecules may 
play a role in the caveolae mediated endocytosis. For example Rab GTPases 
appear to be involved in membrane trafficking (Zerial and McBride 2001) and 
seem to be important regulators of all endocytic and exocytic processes. In 
addition actin and myosin as well as microtubules and molecular motors are part 
of the caveolae mediated endocytosis. A schematic depiction of the signaling 
mechanisms that regulate caveolae-mediated endocytosis, trafficking and 
exocytosis of albumin in endothelial cells is illustrated in Figure 3. 
Several laboratories have described the existence of an albumin-binding 
protein (gp60 or albondin) on the surface of endothelial cells (Tiruppathi, 
Finnegan et al. 1996); (Tiruppathi, Song et al. 1997) and epithelial type II cells 
(Hastings, Folkesson et al. 2004). This gp60 receptor might be responsible for the 
promotion of endocytosis (Vogel, Minshall et al. 2001) and transcytosis of 
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albumin. It has been shown in endothelial cells that albumin docking to gp60 
resulted in clustering of the receptor initiating uptake of the protein (Mehta and 
Malik 2006). 
 
 
1.8 Clathrin-dependent endocytosis 
 
Clathrin-dependent endocytosis has been described in several cells (Pearse 1976; 
Lin, Garbern et al. 1982) and is initiated by the clathrin coat assembly on the 
membrane followed by invagination and fission. Adaptor proteins, such as 
adaptor protein 2 (AP-2), epsin and amphiphysin, enable movement of vesicles 
away from the plasma membrane by facilitating fission (Wakeham, Ybe et al. 
2000). Clathrin coats are key elements of the receptor-mediated (Conner and 
Schmid 2003) and fluid-phase endocytosis from the plasma membrane to the 
early endosomes. They are also involved in transport processes from the trans-
Golgi network to the late endosome (Marsh and McMahon 1999). Phenylarsine 
oxide, a membrane-permeable phosphotyrosine phosphatase inhibitor, prevents 
formation of the clathrin-coated vesicle, thereby impairing clathrin-dependent 
endocytotic processes (Visser, Stevanovic et al. 2004). Chlorpromazine, another 
inhibitor of this pathway, impairs clathrin-dependent endocytosis by modulating 
AP-2 binding to the membranes leading to loss of coated pits from the surface of 
the cell (Wang, Rothberg et al. 1993). A schematic depiction of trafficking of 
macromolecules by clathrin-dependent pathways is illustrated in Figure 4. 
Albumin binds to the gp60 receptor and this leads to a change in the 
conformation of the receptor. This modification enables the receptor to bind to 
AP-2 and to clathrin which is recruited by the assembly protein AP180 (Marsh 
and McMahon 1999), epsin and amphiphysin. 
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Figure 4. Schematic depiction of trafficking of macromolecules by clathrin-dependent 
and caveolae-mediated pathways. 
Several possible pathways for albumin transport in polarized epithelial cells are 
illustrated in this figure. The initial step of albumin trafficking is clathrin-dependent (1) 
or caveolae-mediated (2) endocytosis of the molecule. This step is followed by vesicle 
fission and formation of the early endosome (3; EN). Content of the early endosome is 
either recycled to the internalized membrane domain and transported to the apical 
surface (4) or transporting the content without modification to the opposing surface (5; 
transcytosis). Alternatively a late endosome (6) is formed the content of which is either 
degraded by the lysosomes (7; LY) or further transported through the trans-Golgi-
network (8; TGN) with final processing in the endoplasmatic reticulum (9; ER). 
[Courtesy of Drs Sandvig and van Deurs, reference (Sandvig and van Deurs 1996)]. 
 
 
 15
While transport of albumin across the endothelium is primarily facilitated 
by caveolae-mediated endocytosis (Mehta and Malik 2006), protein uptake and 
its subsequent transport through the epithelial layer of the alveolo-capillary 
barrier is less understood, and remains controversial. This process is of particular 
interest since any excess protein accumulated in the alveolar space must first be 
transported through the epithelial monolayer before it can cross the endothelium. 
It was recently reported that transcytosis of albumin in epithelial cells is, at least 
in part, mediated by caveolae; since clearance of albumin from the alveolar space 
of isolated rat lungs was partially inhibited by the caveolae-disrupting agent 
filipin (John, Vogel et al. 2001). In contrast, mice in which the caveolin-1 gene 
was disrupted, and which do not have morphologically detectable caveolae, not 
only are viable, but they also do not show any defect in albumin transport (Drab, 
Verkade et al. 2001). However, it still needs to be addressed whether 
compensatory pathways exist that might have been induced in the absence of 
caveolin-1. Furthermore, a recent publication has suggested a role for clathrin in 
the uptake of albumin by cultured RLE-6TN rat alveolar epithelial cells 
(Yumoto, Nishikawa et al. 2006), which have several characteristics that are 
similar to alveolar type II cells (Driscoll, Carter et al. 1995). Thus, the exact 
mechanism by which alveolar epithelial cells endocytose proteins from the air 
spaces requires further elucidation. 
 
 
1.9 Transcytosis of albumin through the alveolo-capillary barrier 
 
Once proteins are taken up by the cell, they either cross the cell without 
alterations (transcytosis) (Mehta and Malik 2006) or undergo modifications, such 
as lysosmal or proteasomal degradation (Rivett 1990). Transcytosis is a strategy 
used by multicellular organisms to selectively move material between two 
different environments while maintaining the different compositions of distinct 
compartments in an actin-dependent manner (Tuma and Hubbard 2003). Thus, 
phalloidin oleate, a membrane-permeable peptide, that binds polymeric F-actin, 
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thereby stabilizing it and impairing the function of actin-rich structures, is a 
potent inhibitor of vesicle movement during endo- and trans-cytosis (Stenbeck 
and Horton 2004; Vadasz, Morty et al. 2005). In polarized cells, the net 
movement of molecules can be in either direction, apical to basolateral or the 
reverse, depending on the cargo and particular cellular context of the process. 
The best-studied example of transcytosis in the epithelium is the clathrin-
dependent movement of the secretory immunoglobulin, IgA and its receptor 
(IgA-R) from the basolateral to the apical surface of cells (Mostov and Deitcher 
1986). In particular, Madine Darby canine kidney (MDCK) cells have been 
studied extensively in order to characterize the intracellular intermediates. At 
least three compartments comprise the basolateral-to-apical transcytotic pathway 
of IgA-R in MDCK cells: basolateral early endosomes, a "common" endosome, 
and an apical recycling endosome (Wang, Brown et al. 2000).  
Monensin, an ionophore that disrupts the structure of the Golgi apparatus, 
thereby inhibiting vesicular transport in the cell, is a potent inhibitor of 
transcytosis (Sakagami, Byron et al. 2002). Furthermore, monensin modulates 
the pH in vesicles resulting in a stoppage of vesicle recycling to the cell 
membrane (Hastings, Wright et al. 1994). Transcytosis of albumin has been 
described in detail in the endothelium, where caveolae appear to be the essential 
vesicle carriers responsible for the transport of albumin (Mehta and Malik 2006). 
However, whether albumin trafficking through the epithelium is mediated by 
transcytosis or the protein is degraded in the cell remains to be elucidated. 
The mechanism by which proteins are cleared from the distal air spaces is 
largely unknown. Whether albumin moves through the alveolo-capillary barrier 
passively or is actively taken up by the epithelium is of debate. Since removal of 
protein from the alveolar space is of high clinical importance in the resolution of 
ARDS, understanding the underlying mechanisms may ultimately lead to new 
therapeutic strategies which could not only enhance transport of excess protein to 
the vascular side of the alveolo-capillary barrier but also result in a favorable 
outcome in ARDS. 
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1.10 Aims of our studies 
 
In our studies we aimed to answer the following questions: 
 
• Is albumin transport across the alveolo-capillary barrier an active or a 
passive process? 
o Is intact albumin taken up by the alveolar epithelium or degraded in 
the alveolar space? 
o Is albumin transport across the alveolo-capillary barrier uni-
directional? 
• If the transport is active, what is the mechanism of the uptake by epithelial 
cells in intact lungs? 
o Is the transalveolar albumin transport receptor-mediated? 
o Is uptake of albumin mediated by caveolae- or clathrin-dependent 
endocytic processes? 
• Once albumin is taken up by the epithelium, what is the fate of the 
protein? 
o Is albumin transported intact through the alveolo-capillary barrier 
or degraded? 
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2. Material and Methods 
 
 
2.1 The isolated, ventilated and perfused rabbit lung model 
 
Physiological experiments were performed in isolated, ventilated and perfused 
rabbit lungs, a well established and widely accepted model for pulmonary 
research, which has been extensively used by our group and others in the past 
two decades (Seeger, Walmrath et al. 1994). This physiologically relevant model 
allowed us to investigate alveolar epithelial barrier function in an intact, ex vivo 
organ. Artificial ventilation and perfusion with a blood-free synthetic perfusate 
allowed us to conduct experiments under stable conditions for several hours that 
directly examinate changes in alveolo-capillary barrier function in the absence of 
any input from the rest of the organism. A schematic depiction of the isolated, 
ventilated and perfused rabbit lung model is illustrated in Figure 5. 
 
 
2.1.1 Preparation and isolation of the lung and integration into perfusate 
circuit 
 
Lungs were isolated from healthy, adult male rabbits (New Zealand White, 
Bauer, Neuenstein-Lohe, Germany). Animals weighing 3.0 ± 0.5 kg were 
employed. The ear vein of the rabbits was cannulated and an initial bolus of 
anesthetics was administered containing approximately 0.5 - 0.7 ml of a mixture 
of xylazine (Rompun 20 mg/ml; Bayer, Leverkusen, Germany) and ketamine 
(Ketavet 100 mg/ml; Pfizer, Karlsruhe, Germany) in a ratio of 3:2. Additionally, 
1000 IU/kg heparin (Sodium heparin-25,000-ratiopharm, Ratiopharm, Ulm, 
Germany) was applied intravenously for anticoagulation. A further 1 ml of the 
anesthetics was administered stepwise over three minutes to achieve deep 
anesthesia, although allowing still spontaneous breathing. Animals were placed 
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in a supine position and the legs were fixed. Approximately 8 - 10 ml lidocaine 
(Xylocain 2 %, 20 mg/ml; AstraZeneca, Wedel, Germany) was injected 
subcutaneously into the ventral center of the neck to achieve local anesthesia, and 
a median incision from chin to the cranial thorax was performed. Thereafter, the 
trachea was exposed by blunt dissection and partially transected, and a tracheal 
cannula with an inner diameter of 3 mm was inserted; throughout, the animals 
were artificially ventilated with room air using a Harvard cat/rabbit ventilator 
(Hugo Sachs Elektronik, March Hugstetten, Germany). Subsequently, a second 
median incision was made from the center of the neck to the upper abdomen and 
a mid-sternal thoracotomy was performed. The xyphoid process was clamped 
and elongated, the diaphragm was dissected and the ribs were spread. Parts of the 
parietal pleura, the thymus and the bulk of the pericardium were removed to 
expose the heart, and the apex of the heart was clamped. A loose thread loop was 
formed around the ascendant aorta as well as pulmonary trunk; a bolus of 2 ml 
ketamine/xylazine was administered intravenously and a small incision was made 
in the upper right ventricle. Through the opening a fluid-filled pulmonary artery 
catheter of an inner diameter of 3 mm was inserted into the pulmonary artery and 
fixed with a thread loop; immediately after which the left atrium was opened by 
removing the apex of the heart and the descendent aorta was ligated. Lungs were 
perfused through the pulmonary artery catheter with a blood-free buffer, initially 
at 4 °C at a perfusion rate of 15 ml/min. Thereafter, the lungs, trachea and heart 
are excised en bloc from the thorax. The mitral valves and the chordae tendineae 
were dissected and a second perfusion catheter with an internal diameter of 4 mm 
was introduced via the left ventricle into the left atrium. A tobacco pouch suture 
(Mersilene; Ethicon, St-Stevens-Woluwe, Belgium) was used to fix this second 
catheter at the apex of the left ventricle such that no leakage from the 
catheterization sites, or obstruction of the pulmonary circulation occurred. After 
perfusing at least 1 l of buffer through the lungs to remove any blood from the 
system, the perfusion circuit was closed for the recirculation, while perfusion rate 
was increased from 15 to 100 ml/h temperature was increased to 37 °C. 
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Figure 5. Schematic depiction of the isolated, ventilated and perfused rabbit lung model 
This scheme illustrates the isolated lung freely suspended from a force transducer in a 
heated chamber. Artificial respiration of the lung is depicted by the schematic assembly 
of the ventilation circuit including the ventilator, nebulizer and air reservoir. The arrows 
demonstrate the direction of the air flow. The perfusion of the organ is also shown in the 
figure, and arrows in the perfusion circuit point out the flow direction driven by a 
peristaltic pump. Lungs and the perfusate reservoir are surrounded by gamma detectors 
shielded by lead to allow detection only of radiation emitted from the lung and perfusate 
reservoir, respectively. Biophysical data are processed and amplified by a personal 
computer while the high voltage supply is delivered from a separate personal computer 
with an integrated power support. 
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2.1.2 Artificial respiration 
 
During the lung preparation, natural respiration was replaced with artificial 
respiration with room air. Use of a Harvard cat/rabbit ventilator (Hugo Sachs 
Elektronik, March Hugstetten, Germany) enabled constant gas exchange under 
deep anesthesia. After lungs were isolated and separated from the rest of the 
organism, room-air was supplemented with 4.5 % CO2 to maintain the pH of the 
recirculating buffer between 7.35 - 7.37. Ventilation parameters were set at 30 
breaths/minute, a plateau pressure of 7.5 mmHg (0 mmHg was referenced at the 
hilum of the organ), a ratio between inspiration and expiration of 1:1 to maintain 
uniform ventilation. To prevent atelectasis, a positive end-expiratory pressure 
(PEEP) was set to 2 mmHg, resulting in a tidal volume of approximately 
6 ml/body weight, which is considered protective (ARDSNet 2000). 
 
 
2.1.3 The Perfusion of the isolate lung 
 
A Krebs-Henseleit buffer (Elektrolytlösung IIN; Serag-Wiessner, Naila, 
Germany) containing 120 mM NaCl, 4.3 mM KCl, 1.1 mM Ka2PO4, 2.4 mM 
CaCl2, 1.3 mM magnesium phosphate, 0.24 % [mass/vol] glucose, and 5 % 
[mass/vol] hydroxyethylamylopectin (for plasma expandation) was used for 
perfusion through a tubing system. Approximately 25 ml NaHCO3 (Nabic 8.4 %, 
Braun, Melsungen, Germany) was added to maintain a pH of 7.35 - 7.37. Two 
independent reservoirs, allowing a perfusate change from one reservoir to the 
other without interrupting the circulation, were built into the system. Circulation 
of the perfusate was facilitated by a pump (Masterflex 7518-10; Cole Parmer, 
Vernon Hills, USA) at a flow rate of 100 ml/min. After passage through the 
pulmonary artery and perfusing the lungs, the perfusate left the lung through a 
catheter placed in the left atrium to the “venous“ part of the perfusion. Left atrial 
pressure (LAP) was adjusted by placing a catheter in the venous tubing system 
above the hilum. Temperature of the perfusate was maintained at 37 °C by using 
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a thermostat-controlled water bath (Thermo-Frigomix Braun, Melsungen, 
Germany) and a tube coil dipped into a 37 °C water bath. A pressure sensor was 
placed into the pulmonary artery to measure the pulmonary arterial pressure 
(PAP) and another pressure sensor into the left atrium to measure LAP. 
Immediately after the fluid-filled arterial catheter was placed into the pulmonary 
artery and throughout the rest of the preparation, lungs were perfused at a 
15 ml/min flow rate and at a temperature of 4 °C. After the lungs and heart were 
isolated and removed en block from the thoracic cavity, the flow was increased 
step-wise to 100 ml/min and the temperature to 37 °C over approximately 10 
minutes. During this time lungs were perfused with at least 1 l non-recirculating 
buffer to remove any residual blood cells from the circulation. A filter of 0.2 µm 
mesh size (Pall Cardioplegia; Terumo, Eschborn, Germany) was also placed into 
the circulation system to eliminate remaining cells or pyrogenic aggregates. After 
perfusion reached the desired 100 ml/min flow rate and the buffer was heated to 
37 °C the filter system was removed and the perfusion buffer was recirculated. 
The volume of the recirculating buffer in the system was 300 ml. At the end of 
the preparation and after the lungs were freely suspended from a force transducer 
LAP was set at 2 mm Hg. Throughout the experiment, a bubble trap was present 
in the perfusion system to prevent any air embolisms in the circulation. 
 
 
2.1.4 Nebulization 
 
Substances were delivered to the alveolar space with an ultrasonic nebulizer 
(Optineb, NEBU-TEC, Elsenfeld, Germany). The nebulizer was connected 
directly to the inspiration loop of the ventilator. Filters (Iso-Gard Filter S, 
Hudson, Temecula, USA) were mounted in the outlet of the inspiration and 
expiration loop to prevent contamination of the environment. Characterization of 
the nebulizer revealed an average particle size of 3.2 μm as assessed by 
measurements of the mass median aerodynamic diameter (MMAD). During a  
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10 min aerosolization period, 1.6-1.8 ml of aerosol was generated, and a fraction 
(~60%) of this aerosol (~1 ml) reached the lung the bulk of which was deposited 
into the alveolar space (Figure 6 (Vadasz, Morty et al. 2005; Vadasz, Morty et 
al. 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Distribution of aerosolized Evans blue dye in the isolated, ventilated and 
perfused rabbit lung  
The picture on the left-hand side illustrates a control lung that has been nebulized with 
physiological saline. The right panel shows dissemination of aerosolized liquid 
containing Evans blue dye, which was used to evaluate the efficiency of ultrasonic 
nebulization, in the isolated lung. Uniform staining of the peripheral tissue was evident, 
suggesting that nebulization is a powerful tool to administer substances to the alveolar 
compartment. 
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2.1.4.1 Tracers 
 
125I-bovine serum albumin (125I-albumin) (PerkinElmer, Boston, USA) was used 
to monitor protein transport in the lung, as well as in cell culture experiments. 
The specific activity of the 125I-albumin was 3 μCi/μg protein. Approximately 
6 µCi (and thus 2 µg) of albumin was deposited into the alveolar space during the 
10-min nebulization. About 12 µCi of [3H]mannitol (PerkinElmer, Boston, USA) 
was applied to the distal air spaces to measure paracellular transport of small 
solutes. In the case of isolated, ventilated and perfused rabbit lung experiments, 
tracers were deposited into the alveolar space by ultrasonic nebulization; while in 
cell culture experiments solute, radio-labeled substances were directly added to 
the cell culture medium.  
 
 
2.1.4.2 Determination of the intactness of 125I-albumin 
 
Intactness of 125I-albumin was assessed by two independent methods. 
Trichloroacetic acid (TCA) was applied to precipitate protein content of BAL 
and perfusate samples and samples of non-nebulized aliquots of 125I-albumin, as 
described previously (Hastings, Folkesson et al. 1995). Briefly, 1 ml samples 
were precipitated with 2 ml 20 % TCA [vol/vol], and spun at 14,000 rpm for 
10 min in a Hettich Micro 22 R centrifuge (Tuttlingen, Germany). Supernatants, 
which contained the cleaved fractions of 125I-albumin, were transferred to a new 
Eppendorf tube and the amount of γ-emission was quantified by a γ-counter 
(Packard, Dreieich, Germany). The amount of γ-emission was compared to 
samples, which contained both the supernatant and the pellet and thus included 
both cleaved and intact fractions of the radio-labeled protein. The amount of 
intact 125I-albumin in BAL and perfusate samples was also determined by 
centrifugal filters (Amicon; Centricon, Bedford, USA) with a molecular cut-off 
of 50 kDa, as recommended by the manufacturer. From each BAL and perfusate 
sample 2 ml was administered to the sample reservoir of the filter device and 
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than spun in a Rotina 46 R (Hettich, Kirchlengern, Germany) centrifuge at 4,000 
rpm for 10 min. Since intact albumin is ~69 kDa, samples were separated into 
two fractions by centrifugation. The first fraction, containing all cleaved 
125I-albumin, appeared in the filtrate vial; and a second fraction, which contained 
intact 125I-albumin, remained in the sample reservoir. The amount of γ-emission 
in these fractions was quantified by a γ-counter (Packard, Dreieich, Germany). 
 
 
2.1.4.3 Measurement of Tracer Exchange 
 
Gamma-detectors (Target System Electronic, Solingen, Germany) were used to 
detect 125I-albumin and were connected to an automated high-voltage power 
supply integrated into a personal computer system with data processing. Four 
detectors, two of them placed around the lungs and two around the perfusate, 
registered movements of 125I-albumin in real-time. The [3H]mannitol tracer 
kinetics were monitored by perfusate sampling at 0, 5, 10, 20, 40, 80 and 120 
min after the end of the nebulization step and was quantified by scintillation 
counting in a Canberra Packard β-counter (Packard, Dreieich, Germany). 
 
 
2.1.4.4 Calculation of Tracer Kinetics 
 
Counts of the gamma emitter 125I-albumin were recorded continuously by 
gamma-detectors every 30 s over the entire time-course of the experiment. The 
starting point of each tracer clearance measurement in the lung, as well as in the 
perfusate, was set at the end of the nebulization, and at this time point the amount 
of radiation in the lung was referenced to 100 % and the amount of radiation in 
the perfusate to 0 %. The clearance rate from the lungs, and transit into the 
perfusate, were calculated by measuring the area above the curve (AAC) as 
determined by the following equation: 
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AAC = [(100-A) × T]- {[-(100-A) / ℮] × [1-exp (℮ × T)]} 
 
where “A” is the asymptote of the exponential curve, “T” is the time; and “℮” is 
the exponential function of the curve. A correction for additive radiation over the 
lung was applied (in vessels of the organ and tubes close to the lung; measured 
by lung detectors, approximately 15 ml). However, this additive activity did not 
exceed 5.5 % of the radioactivity deposited into the alveoli. Because different 
tracer yields were detected over the lung and the perfusate (for geometric 
reasons), detectors surrounding the reservoir were calibrated to match the yield 
of tracer detection over the lung, thereby allowing direct comparison of the 
obtained values for 125I-albumin tracer quantities. Discontinuous sampling of the 
perfusate enabled assessment of intactness of the alveolo-capillary barrier, as 
measured by [3H]mannitol movement into the circulation, a marker of passive 
paracellular permeability. 
 
 
2.1.5 Bronchoalveolar lavage 
 
At the conclusion of each experiment a bronchoalveolar lavage (BAL), was 
performed. Immediately after determination of ventilation and perfusion, the left 
lung was ligated and 30 ml of isomolar mannitol (Mannit-15%, Serag Wiessner, 
Naila, Germany) was instilled into the right lung and gently reaspirated three 
times to recover lavage fluid. Approximately 75 – 80 % of the instilled fluid was 
recovered, and the entire procedure took less than 30 s. The recovered fluid was 
then centrifuged at 1000 revolutions per minute (rpm) in a Hettich Micro 22 R 
centrifuge, (Tuttlingen, Germany) for 10 min to pellet any cellular debris from 
the lavage fluid. 
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2.1.6 Monitoring parameters in the isolated, ventilated and perfused lungs 
 
Ventilation pressure (VP), left atrial pressure (LAP) and pulmonary artery 
pressure (PAP) were detected with catheters placed in the expiration loop of the 
ventilator, the left atrium and the pulmonary artery. An electromechanical 
pressure converter (Combitrans, Braun, Melsungen, Germany) allowed 
digitalization of these signals. During every experiment in the isolated lung 
model, the weight of the organ was measured and changes in the weight were 
detected by a force transducer. All analog signals were amplified, converted to 
digital signals and the use of the PlotIT 3.1 software (Scientific Programming 
Enterprises, SPE, USA) enabled an on-line graphical demonstration of LVP, 
PAP, VP and weight on a personal computer during the experiment (Figure 7). 
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Figure 7. Schematic depiction of the experimental protocol in the isolated, ventilated 
and perfused rabbit lungs.  
Original recordings of pulmonary artery pressure (PAP), left atrial pressure (LAP) and 
lung weight of a control experiment are illustrated. After a 30 min steady-state period, 
lungs were first nebulized with pharmacological agents or their vehicles. After an 
additional 30 min period lungs were aerosolized with physiological saline containing 
125I-albumin and [3H]mannitol, and the clearance of the radio-labeled albumin was 
monitored for 120 min in real-time by γ-detectors placed around the lungs and the 
perfusate reservoir. Movement of [3H]mannitol across the alveolo-capillary barrier was 
detected from perfusate samples at timed intervals. Both nebulizations resulted in a 
transient weight gain of the lung. The first aerosolization deposited ~0.5 ml liquid to the 
distal air space, hence the 0.5 g transient weight gain (dashed box). A second transient 
weight gain of the lung induced by the second nebulization (fluid challenge 
approximately 1 ml) is indicated by the solid box. 
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2.1.7 Substances applied in the physiological model 
 
Pharmacological agents applied to the isolated, ventilated and perfused rabbit 
lung model are listed in Table I. All chemicals listed in Table I were from Sigma 
(St. Louis, USA). 
 
Table I 
 
Chemical agents applied to the isolated rabbit lungs 
 
 
Application 
 
 
Agent 
 
Vehicle 
Final 
concentration 
 
Administration 
    
BSA 
 
NaCl 2 mg/ml ELF 
BSA NaCl 20 mg/ml Perfusate 
Competitors 
    
    
EDTA 
 
NaCl 10 µg/ml ELF 
AEBSF DMSO 0.25 mg/ml ELF 
Protease 
inhibitors 
    
    
    
NEM 
 
NaCl 5 µg/ml Perfusate 
    
Filipin DMSO 2 µg/ml Perfusate 
Caveolae 
inhibitors 
    
    
Chlorpromazine 
 
NaCl 5 µg/ml ELF 
Phen ox DMSO 30 µg/ml ELF 
Clathrin 
inhibitors 
    
    
Phalloidin oleate
 
DMSO 1 µg/ml ELF 
Monensin Methanol 15 µg/ml ELF 
Transcytosis 
inhibitors 
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2.1.8 Experimental protocol for the isolated, ventilated and perfused lungs 
 
The time-course of all experiments was 180 min. Experimental protocols are 
illustrated in Figure 7. Lungs included in our study had no signs of hemostasis, 
edema or atelectasis; exhibited a constant mean PAP and VP in the normal range; 
and were isogravimetric during an initial steady-state period of 30 min. After the 
conclusion of the steady-state period, lungs were nebulized with an Optineb 
ultrasonic nebulizer (Nebu-Tec, Elsenfeld, Germany), connected directly to the 
inspiration loop of the ventilator. Either pharmacological agents (diluted in 
dimethyl sulfoxide (DMSO) or in methanol in physiological saline (1 % [vol/vol] 
in both cases) or saline in the presence of the vehicles (for control experiments) 
were aerosolized into the lungs. A list of these pharmacological agents together 
with their suppliers and final concentrations in the ELF and perfusate are listed in 
Table I. The first nebulization (duration 5 min) deposited 0.5 ml of fluid into the 
alveolar space, with a concomitant 0.5 g transient increase in lung weight, 
attributable to this fluid that was nebulized into the lung (Figure 7 dashed box). 
In some experiments this nebulization step was replaced by administration of 
pharmacological agents to the perfusate in order to target the vascular 
compartment of the lung. 
Lungs were then allowed to re-establish baseline conditions for 30 min 
after which radioactive tracers were applied by a second ultrasonic nebulization 
over 10 min. This second nebulization deposited 1 ml of fluid into the alveolar 
space, with a concomitant 1 g increase in lung weight, attributable to this fluid 
that was nebulized into the lung (Figure 7, solid box). Transport of 125I-albumin 
was monitored real-time from the beginning of the tracer nebulization until the 
conclusion of the experiment with the help of gamma-detectors, while movement 
of [3H]mannitol was assessed by discontinuous perfusate sampling, as described 
in section 2.1.4.3. Additionally, at the conclusion of the experiment, a BAL was 
performed. As described in section 2.1.4 experiments were conducted at 37 °C, 
however, selected experiments were performed at 22 °C or at 4 °C to assess 
temperature dependence. 
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In some additional experiments, fluorescein isothiocyanate (FITC)-labeled 
albumin influx from the perfusate into the alveolar space was measured to 
address whether movement of albumin was bi-directional. The FITC-albumin 
was administered to the perfusate (at a final concentration of 0.16 mg/ml) 30 min 
after the end of the steady-state period. The FITC-albumin concentrations were 
determined from BAL fluids (200 µl) in a Fusion microplate spectrofluorimeter 
(Packard; Dreieich, Germany) at an emission wavelength of 480 nm and an 
excitation wavelength of 520 nm, as described previously (Lecuona, Saldias et al. 
1999). 
 
 
2.2. Cellular experiments 
 
Experiments in alveolar epithelial monolayers were performed to further dissect 
the mechanisms by which uptake of albumin by the alveolar epithelium occurred, 
and to verify the results that were obtained from the isolated, ventilated and 
perfused rabbit lung model. For these experiments, cultured human epithelial 
cells (A549; ATCC-No.: CCL-185) were employed. This cell-line of human 
adenocarcinoma origin has been extensively studied by several research groups 
and represents a both well-characterized and excellent model system for primary 
alveolar epithelial type II cells. 
 
 
2.2.1 Culturing the cells 
 
The A549 cells were cultured in Dulbecco’s modified Eagle’s medium/Ham’s 
F12 medium (DMEM/F12; 1:1, GIBCO, Invitrogen, Karlsruhe, Germany) 
supplemented with 10 % [vol/vol] fetal calf serum (FCS; PAA Laboratories, 
Egelsbach, Germany), 1 % [vol/vol] glutamine, 1 % [vol/vol] penicillin/ 
streptomycin (both from PAN-Biotech, Aidenbach, Germany), 1 % [vol/vol] 
non-essential amino-acids and 1 % [vol/vol] vitamins (both from GIBCO, 
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Invitrogen, Karlsruhe, Germany). Cells were grown in 75 cm2 tissue culture 
flasks (Cellstar; Greiner Bio-One, Frickenhausen, Germany) for two days to 80 - 
90 % confluence (approximately 4 - 5 million cells) in a Haereus cell culture 
incubator (Haereus Instruments, Hanau, Germany) at a temperature of 37 °C, 80 - 
95 % relative humidity and 5 % carbon dioxide. For subculturing, culture 
medium was removed and the cells were rinsed with DMEM/F12 medium twice, 
after which 5 ml of 0.25 % trypsin-EDTA (PAN-Biotech, Aidenbach, Germany) 
was added and cells were placed in a cell culture incubator for an additional 5 
minutes to enhance cell detachment. To achieve complete cell detachment, cells 
were resuspended in medium containing 1.5 ml FCS and 5 ml DMEM/F12 in the 
flasks. The suspended cells were then transferred to a 15 ml conical tube (BD 
Biosciences, Heidelberg, Germany) and were centrifuged in a Rotina 46 R 
centrifuge (Hettich, Kirchlengern, Germany) at 1200 revolutions per minute at 
15 °C for 10 min. The supernatant was removed and discarded and the cell pellet 
was resuspended in culture media and 1.5 million cells were seeded in 75 cm2 
tissue culture flasks for further subculturing. For our experiments, A549 cells of 
passage 1 to 10 were employed and approximately 125,000 cells were placed into 
each well of a six well tissue culture plate (Cellstar; Greiner Bio-One, 
Frickenhausen, Germany). Under these culture conditions, A549 cells doubled 
approximately every 22 h. Therefore, at the time of the experiments, 44 - 48 h 
after plating, approximately 500,000 cells per dish were counted. 
 
 
2.2.2 Pharmacological agents applied to the cell culture model 
 
Pharmacological agents applied to monolayers of A549 cultured epithelial cells 
are included in Table II. All chemicals listed in Table I and II were from Sigma 
(St. Louis, USA). 
 33
 Table II 
 
Chemical agents applied to A549 cells 
 
 
Application 
 
 
Agent 
 
Vehicle 
Final 
concentration 
   
BSA PBS 20 mg/ml Competitor 
   
   
NEM 
 
PBS 100 µg/ml 
Filipin DMSO 2 µg/ml 
Caveolae 
inhibitors 
   
   
Chlorpromazine 
 
PBS 30 µg/ml 
Phen ox DMSO 5 µg/ml 
Clathrin 
inhibitors 
   
 
 
2.2.3 Protocol of cellular experiments 
 
At the beginning of the experiments, media was removed from the culture plates 
and cell layers were rinsed briefly with Dulbecco’s phosphate buffered saline 
(DPBS; PAN Biotech, Aidenbach, Germany) supplemented with 0.1 mM CaCl2 
dihydrate (Calbiochem, San Diego, USA) 0.5 mM MgCl2 6H2O and 5 mM 
glucose (both from Sigma, St. Louis, USA) (DPBS-G). Cells were then pre-
incubated for 10 min with 2 ml of DPBS-G followed by a pre-incubation with 
pharmacological agents or their vehicles. The details of treatments with these 
agents are described in Table II. After treatment of the cells with these agents 
2 ml of DPBS-G containing 125I-albumin was applied to the cells in the presence 
or absence of these agents for different time periods. 125I-albumin uptake was 
terminated after 2.5, 5, 10, 30 or 60 min by aspiration of the medium and the 
addition of ice-cold DPBS. Wells were washed thoroughly with ice-cold DPBS 
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to remove any residual tracer from the surface of the cells. Cells were then 
solubilized by treating them with a cell culture lysis reagent (Promega, Madison, 
WI, USA) at 4 °C for 5 minutes, and 125I-albumin in the cell extracts was 
quantified by γ-emission counting in a Packard γ-counter (Packard, Dreieich, 
Germany). 
 
 
2.2.4 Assessment of cell viability 
 
Cell viability was tested with the Trypan Blue exclusion dye method (Perry, 
Epstein et al. 1997). Cells were plated in six-well plates exactly as described 
above and viability of control cells and cells exposed to drugs or their vehicles 
alone were assessed by adding 50 μl of Trypan Blue solution (0.4 % [mass/vol] 
Trypan blue in PBS) in culture medium. After 1 – 2 min, the number of dead 
cells, which retained the dye, was compared to the total number to calculate the 
mortality percentage. 
 
 
2.3 Statistical analysis of data 
 
Numerical values are given as the mean ± standard deviation (SD). Comparisons 
between two groups were made using an unpaired, two-tailed Student’s t-test. 
Intergroup differences of three or more experimental groups were assessed by 
using a one-way analysis of variance (ANOVA) with post hoc Dunnett-test, 
when comparing values only to controls or Tukey-test for multiple comparisons. 
p values < 0.05 were considered significant. GraphPad Prism 4 for Windows 
software (GraphPad Software; San Diego, USA) was used for data plotting and 
statistical analysis. 
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3. Results 
 
3.1 Clearance of albumin from the alveolar space of isolated rabbit lungs 
is an active process 
 
At 37 °C, 29.8 ± 2.2% of the 125I-albumin deposited to the alveolar space was 
cleared from the lungs by the end of the experiment (Figure 8). This movement 
of albumin was temperature-dependent, as experiments conducted at 22 °C and at 
4 °C resulted in a significantly lower clearance of the nebulized 125I-albumin 
(16.2 ± 1.1 % and 3.7 ± 0.4 %, respectively; Figure 8). Albumin clearance at 
4 °C is attributable exclusively to passive transport processes, because active 
processes are shut down at this temperature (Rutschman, Olivera et al. 1993). 
Passive epithelial paracellular permeability for solutes, as assessed by 
[3H]mannitol clearance from the lung, was not significantly affected by low 
temperature, when compared with control lungs at 37 °C (Figure 9). Thus, we 
reasoned that clearance of 125I-albumin from the lungs at 37 °C that was not 
cleared at 4 °C was attributable to active processes, because passive processes 
were unaffected under all experimental conditions. Approximately 88 % of the 
125I-albumin transport was active, as measured by the difference between the area 
above the curve for the experiments conducted at 37 °C and 4 °C (Figures 8 and 
9). 
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Figure 8. Mean 125I-albumin clearance from isolated, ventilated and perfused rabbit 
lungs is inhibited by low temperature.  
Lungs were maintained either at 37 °C (red), 22 °C (green) or 4 °C (blue) and 60 min 
after establishing a steady-state equilibrium, 125I-albumin was deposited into the 
alveolar space by nebulization. Elimination of the tracer from the lungs was monitored 
over 120 min. Counts were set at 100 % immediately after nebulization of 125I-albumin 
tracer into the lungs. Each data point represents the mean of at least six independent 
experiments. For clarity, standard deviations have been omitted, however, they are 
incorporated into analyzes of these data in Figure 9. 
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Figure 9. Low temperature blocks albumin transport without affecting passive 
paracellular epithelial permeability of intact lungs.  
125I-albumin transport (solid bars) was quantified from the data presented in Figure 8, as 
described in the “Materials and Methods” section. The 125I-albumin transport in lungs 
maintained at 37 °C was set at 100%, while albumin transport in lungs maintained at 
low temperature was expressed relative to this control value. Passive [3H]mannitol flux 
(open bars) was monitored by scintillation counting of perfusate samples taken at timed 
intervals after nebulization of the [3H]mannitol tracer into the lungs, as described in 
“Materials and Methods”. The passive [3H]mannitol flux in lungs maintained at 37 °C 
was set at 100 %, while mannitol flux in lungs maintained at low temperature was 
expressed relative to this control value. Data represent the mean ± SD (n = 6 for all 
groups); ***, p < 0.001, compared to control; ###, p < 0.001, compared to control, or to 
lungs maintained at 22 °C. 
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3.2 Radio-labeled albumin nebulized into isolated rabbit lungs remains 
intact in the alveolar space over the course of the experiment 
 
To assess the intactness of 125I-albumin during the experimental time-course 
TCA precipitation was employed. The amount of 125I-albumin in aliquots which 
were not nebulized but had been designed for aerosolization was found to be 
95.4 ± 0.7 % intact (Figure 10). Similarly, after nebulization the bulk of radio-
labeled albumin was intact in the alveolar space (87.6 ± 2.0 %) as measured from 
BAL samples directly after nebulization. The amount of intact radio-labeled 
albumin remained unchanged throughout the experiment, since 86.9 ± 3.4 % of 
the 125I-albumin was TCA-precipitated at the end of the experiments (Figure 10). 
Intactness of 125I-albumin was also assessed by centrifugal filter fractionation in 
samples obtained the same way described above. When a centrifugal filter device 
with a molecular cut-off of 50 kDa was used, results obtained were almost 
identical to those obtained by TCA precipitation. Before nebulization, 
93.2 ± 1.2 % of 125I-albumin was intact, while directly after nebulization, 
89.2 ± 1.6 % and by the end of the experiment 87.8 ± 2.1 % of the radio-labeled 
albumin remained intact. 
 
 
3.3 Transport of albumin between the alveolar and vascular space of 
isolated lungs is uni-directional 
 
To address the question of whether albumin transport across the alveolo-capillary 
barrier was uni-directional (from the alveolar to the vascular compartment) or 
bi-directional, we administered FITC-albumin to the vasculature, and the flux of 
FITC-albumin into the alveolar space was measured. Experiments were 
performed either at 37 °C or at 4 °C, and concentrations of the FITC-albumin in 
the ELF and the perfusate were measured as described in detail in the “Materials 
and Methods” section. While approximately 30 % of the 125I-albumin deposited 
into the alveolar space was cleared over the time-course of the experiment (120 
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min) at 37 °C (Figure 8), only 6.0 ± 1.1 % of the FITC-albumin applied to the 
vasculature appeared in the alveolar space over the same time-course at 37 °C 
(Figure 11).  
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Figure 10. 125I-albumin in the alveolar space remains intact throughout the experiment 
Intactness of 125I-albumin was assessed by TCA precipitation before (Start), directly 
after nebulization (After neb), and at the end of the experiment (End). Data represent the 
mean ± SD (n = 6 for all groups). 
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Figure 11. Transport of albumin accross the alveolo-capillary barrier is 
uni-directional. 
The FITC-albumin was administered to the perfusate and quantified in the ELF from 
BAL samples. Experiments were conducted at 37 °C or 4 °C. The FITC-albumin 
concentration in the perfusate was set to 100 %, and the concentration of FITC in the 
BAL was calculated as a percentage of the FITC concentration in the perfusate. Bars 
represent the mean ± SD (n = 6 for all groups). 
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When experiments at 4 °C were performed, nearly identical transport rate of 
FITC-albumin from the vascular to the alveolar space was measured 
(5.3 ± 0.5 %) (Figure 11), suggesting that the bulk of the FITC-albumin 
movement was probably mediated by passive paracellular processes. In line with 
these findings, when 125I-albumin transport from the alveolar to the vascular 
compartment was measured at 4 °C, a similar clearance rate (3.7 ± 0.4 %), 
compared to 100 % in the perfusate, was calculated (Figure 8). These data 
collectively support the hypothesis that movement of albumin through the 
alveolo-capillary barrier was predominantly uni-directional, occuring from the 
alveolar to the vascular space. 
 
 
3.4 Albumin is taken up intact by the alveolar epithelium of isolated rabbit 
lungs 
 
In further experiments which were designed to clarify whether albumin was 
degraded by proteases in the ELF, or taken up intact by the alveolar epithelium, 
we aerosolized protease inhibitors to the distal air spaces to inhibit protease 
activity. We applied EDTA for metallo-proteases (Chiancone, Thulin et al. 1986) 
as well as AEBSF for the inhibition of serine protease activity (Lunn and 
Sansone 1994). Serine- and metallo-proteases represent the main source of 
protease activity in the alveolar space (Gross 1995; Greenlee, Werb et al. 2007). 
When clearance of 125I-albumin from the alveolar space was measured after 
pre-nebulization of AEBSF, transit of 125I-albumin across the alveolo-capillary 
barrier was unchanged when compared to control lungs that have been 
pre-nebulized with physiological saline (30.2 ± 2.2 % and 30.4 ± 1.8 %, 
respectively; Figure 12). Similarly, pre-nebulization of EDTA did not change the 
rate of movement of the radio-labeled protein either (30.7 ± 1.4 %; Figure 12). 
These results suggested to us that degradation activity, mediated by serine and 
metallo proteases in the ELF, had no effect on albumin transport across the 
alveolo-capillary barrier. 
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Figure 12. Active clearance of 125I-albumin from the alveolar space is not affected by 
metallo- and serine proteases. 
Control lungs (red) were maintained at 37 °C and sham-nebulized with 0.1 % [vol/vol] 
DMSO in physiological saline 30 min after establishing steady-state equilibrium. In 
additional experiments, instead of sham-nebulization, AEBSF (blue) or EDTA (yellow) 
was nebulized to lungs and after a further 30 min, 125I-albumin tracer was deposited into 
the alveolar space, and elimination of this tracer from the lung was monitored as 
described in the legend to Figure 8. Each data point represents the mean of six 
independent experiments. 
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3.5 Albumin movement across the alveolo-capillary barrier is a saturable, 
active process 
 
In some experiments, lungs were pre-nebulized with a 1000-fold molar excess of 
unlabeled albumin (compared to the radioactive tracer) prior to aerosolization of 
125I-albumin to investigate whether transit of the radio-labeled protein can be 
inhibited by competition. Deposition of the excess native albumin into the 
alveolar space significantly decreased the active transport of 125I-albumin from 
the air space to the vascular compartment of the lung, since the rate of active 
transport of the tracer was inhibited by 31.6 ± 1.2 % compared to control lungs 
that had been pre-nebulized with physiological saline (Figure 13 A and B). 
Under normal conditions, the perfusate does not contain any protein, and 
thus an albumin gradient between the two sides of the alveolo-capillary barrier 
occurs. In additional studies, when excess unlabeled albumin was administered to 
the perfusate to eliminate this oncotic gradient between the alveolar and the 
vascular compartments, no effect on 125I-albumin transit was observed (Figure 
13 A and B) further suggesting that passive movement of the radio-labeled 
protein was not a significant contributor to albumin clearance from the air space. 
These data indicate that the vast majority of the transepithelial albumin 
movement is mediated by active transport processes. 
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Figure 13. Excess intra-alveolar (but not intravascular) native albumin inhibits 
125I-albumin clearance from intact rabbit lungs.  
(A) Control lungs (red) were maintained at 37 °C and sham-nebulized with 
physiological saline 30 min after establishing a steady-state equilibrium. In some 
experiments, instead of sham-nebulization, a 1000-fold molar excess of native albumin 
was nebulized into the lungs (green). Alternatively, excess native albumin (20 mg/ml) 
was applied to the perfusate of the lungs (blue) after establishing a steady-state 
equilibrium. After a further 30 min, 125I-albumin tracer was nebulized to the lungs, and 
elimination of this tracer from the lung was monitored over 120 min, as described in the 
legend to Figure 7. (B) Active 125I-albumin transport was set at 100% in control lungs 
and active transport of the tracer in excess native albumin-treated lungs was expressed 
relative to this control value. Bars represent the mean ± SD (n = 6 for all groups); 
*, p < 0.05. 
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3.6 Albumin is taken up by A549 cells via an active process 
 
To investigate whether albumin was taken up actively by the mammalian 
epithelium, A549 monolayers were pre-treated with a 1000-fold molar excess of 
unlabeled albumin (compared to the radioactive tracer), prior to 125I-albumin 
administration, to assess the effect of competition. In control experiments, uptake 
of 125I-albumin was found to be bi-exponential, where a rapid initial phase 
(typically in the first 10 min) was followed by a slower uptake rate later (between 
10 and 60 min), with an area under the curve (AUC) of 91.4 ± 7.1 nCi/h 
(Figure 14). Pretreatment with the native albumin markedly inhibited the uptake 
of the radio-labeled tracer (AUC 23.2 ± 3.4 nCi/h; Figure 14), indicating a 
competitive antagonistic effect of the unlabeled albumin on 125I-albumin uptake. 
Thus the γ-radiation that occurred in the presence of the 1000-fold molar excess 
of unlabeled albumin was considered as binding of 125I-albumin to the cell 
surface, and the difference between this and the control curve was considered as 
the active 125I-albumin uptake.  
 
 
3.7 Albumin movement from the alveolar compartment to vasculature 
involves caveolae-mediated endocytosis 
 
To address the question of whether caveolae-mediated endocytosis was involved 
in the movement of 125I-albumin from the air space to the vasculature, NEM 
(Schnitzer, Allard et al. 1995) or filipin (Schnitzer, Oh et al. 1994) were 
administered to the vascular compartment of the isolated lung prior to the 
nebulization of 125I-albumin. Application of NEM resulted in a significant 
inhibition of the transit rates of the radio-labeled protein from the distal air space 
(36.7 ± 5.4 %; Figure 15 A and B). Similarly, when filipin was administered to 
the perfusate prior to 125I-albumin aerosolization the active component of the 
tracer transit was blocked by 31.6 ± 4.8 % (Figure 15 A and B). These data 
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suggested that caveolae-mediated endocytosis plays a role in albumin movement 
from the alveolar to the vascular compartment. 
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Figure 14. Uptake of 125I-albumin by human epithelial A549 cells was blocked by 
excess native albumin. 
Subconfluent monolayers of A549 cells plated in 6-well tissue culture dishes were 
pre-incubated for 30 min with 2 ml of DPBS-G in the absence or presence of excess 
native albumin. The media was then removed and 2 ml of DPBS-G containing 
125I-albumin was applied to the cells and uptake of the radio-labeled protein was 
terminated after 2.5, 5, 10, 30 or 60 min from cell lysates by gamma-emission counting. 
Each data point represents the mean of at least four independent experiments. 
***, p < 0.001, compared to control. 
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Figure 15. Caveolae-mediated endocytosis is required for active clearance of 
125I-albumin from the alveolar space to the vascular compartment. 
(A) Thirty minutes after achieving steady-state, lungs were either sham-treated (red) or 
were treated with NEM (blue) or filipin (bright blue) in 0.1 % (vol/vol) DMSO instead 
of the sham application. After a further 30 min, 125I-albumin tracer was deposited into 
the alveolar space, and elimination of this tracer from the lung was monitored as 
described above. Each data point represents the mean of six independent experiments. 
(B) Active 125I-albumin transport was set at 100% in control lungs and active transport 
of the tracer in caveolae-mediated endocytosis inhibitor-treated lungs was expressed 
relative to this control value. Values represent the mean ± SD (n = 6 for all groups); 
**, p < 0.01. 
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Figure 16. 125I-albumin uptake by A549 cells is mediated by caveolae-mediated 
endocytosis. 
(A) Subconfluent monolayers of A549 cells plated in 6-well tissue culture dishes were 
pre-incubated for 30 min either with filipin (blue) or N-ethylmaleimide (bright blue) or 
their vehicle. The medium was removed and replaced with medium containing 
125I-albumin in the presence of the inhibitor or vehicle. The uptake of the radio-labeled 
protein was determined after 2.5, 5, 10, 30 or 60 min from cell lysates by gamma-
emission counting. Each data point represents the mean ± SD of at least four 
independent experiments. (B) 125I-albumin uptake was expressed as area under the curve 
and compared to vehicle-treated controls which were set at 100 % **, p < 0.01, when 
compared to control. 
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3.8 Albumin uptake by A549 cells requires caveolae function 
 
To further investigate whether caveolae function was necessary for the alveolar 
epithelial uptake of albumin, this process was assessed in A549 cells. In the 
presence of filipin or NEM, the uptake of 125I-albumin by A549 cells was 
inhibited to a similar extent as was noted in the isolated lung model. These 
results are summarized in Figure 16 A and B. These data suggested that 
caveolae-mediated endocytosis was an important element of albumin uptake by 
A549 cells. 
 
 
3.9 Albumin movement from the alveolar compartment to vasculature 
includes clathrin-dependent endocytosis 
 
In additional experiments we further investigated the mechanisms of endocytosis 
that might mediate the transport of 125I-albumin from the alveolar compartment 
to the vasculature, and assessed a role for clathrin-dependent endocytosis. When 
the clathrin-mediated endocytosis inhibitor, phenylarsine oxide (Visser, 
Stevanovic et al. 2004), was nebulized into the alveolar space, a significant 
decrease in active 125I-albumin transit from the alveolar epithelium to the 
vascular compartment of the lung was evident, since the rate of 125I-albumin 
active transport was inhibited by 30.2 ± 1.2 % (compared to control lungs that 
had been pre-nebulized with physiological saline; Figure 17 A and B). 
Additionally, in further experiments, another clathrin-dependent endocytosis 
inhibitor, chlorpromazine (Wang, Rothberg et al. 1993), was administered to the 
air spaces prior to aerosolization of 125I-albumin to confirm the findings with 
phenylarsine oxide. Application of chlorpromazine, similarly to what was 
observed with phenylarsine oxide, resulted in a clear decrease (33.1 ± 2.2 %, 
compared to control lungs treated with vehicle only; Figure 17 A and B) in the 
transport rate of aerosolized 125I-albumin from the alveolar compartment to the 
vasculature.
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Figure 17. Clathrin-dependent endocytosis is required for the active clearance of 
125I-albumin from the alveolar space. 
(A) Identical to experiments illustrated in Figure 7, control lungs were sham-nebulized 
with 0.1 % [vol/vol] DMSO in physiological saline (red) 30 min after achieving steady-
state. In additional experiments, lungs were either aerosolized with chlorpromazine 
(Chlorprom, blue) or with phenylarsine oxide (Phen ox, bright blue) instead of the 
sham-nebulization. 125I-albumin tracer was deposited into the alveolar space after a 
further 30 min and elimination of the tracer from the lung was monitored over 120 min. 
Each data-point represents the mean of six independent experiments. (B) Active 
125I-albumin transport was set at 100% in control lungs and active transport of the tracer 
in clathrin-dependent endocytosis inhibitor-treated lungs was expressed relative to this 
control value. Bars represent the mean ± SD (n = 6 for all groups); **, p < 0.01. 
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3.10 Albumin uptake in A549 cells involves clathrin-dependent endocytosis 
 
To address the role of clathrin-dependent endocytosis in 125I-albumin uptake by 
A549 cells, two clathrin-dependent endocytosis inhibitors, phenylarsine oxide 
(Visser, Stevanovic et al. 2004) and chlorpromazine (Wang, Rothberg et al. 
1993), were applied separately to the cell monolayer. In both experimental 
groups, 125I-albumin uptake was markedly impaired by these inhibitors as 
expressed by the decrease in the AUC (63.9 ± 4.1 % and 63.2 ± 5.9 %, 
respectively) compared to uptake assessed in control experiments, where vehicle 
only was applied (Figure 18 A and B). These data suggested that clathrin-
dependent endocytosis was required for albumin uptake by A549 cells. 
 
 
3.11 Albumin uptake in A549 cells requires both caveolae-mediated and 
clathrin-dependent endocytic processes 
 
Since both caveolae- and clathrin-dependent endocytosis appeared to be 
important for albumin uptake by the alveolar epithelium, the combined role of 
these two endocytic processes was assessed by simultaneously applying 
inhibitors of both processes. Therefore, we applied the clathrin inhibitor, 
chlorpromazine, and the caveolae inhibitor filipin, together or separately. 
Consistent with the previous findings, both chlorpromazine and filipin 
significantly inhibited 125I-albumin uptake in A549 cells (Figure 19 A and B). 
Importantly, when these inhibitors were applied in combination, a significantly 
greater inhibition occurred than did after the drugs were administered separately 
(Figure 19 A and B). These effects were not due to cytotoxicity of any of the 
drugs applied. Under control conditions, approximately 1-2 % of cells were 
stained by the Trypan Blue dye, representing dead cells. None of the 
pharmacological inhibitors had any effect on cell viability, since the amount of 
stained cells did not exceed 2 % under any experimental condition. 
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Figure 18. 125I-albumin uptake by A549 cells is mediated by clathrin-mediated 
endocytosis 
(A) Subconfluent monolayers of A549 cells plated in 6-well tissue culture dishes were 
preincubated for 30 min either with phenylarsine oxide (Phen ox, blue) or 
chlorpromazine (black) or their vehicles (red). The medium was then removed and 
replaced with medium containing 125I-albumin in the presence or absence of the 
inhibitors. Uptake of the radio-labeled protein was determined after 2.5, 5, 10, 30 or 
60 min from cell lysates by gamma-emission counting. Each data point represents the 
mean of at least four independent experiments. (B) 125I-albumin uptake was expressed 
as area under the curve and compared to vehicle-treated controls which were set at 
100 % **, p < 0.01, when compared to control.  
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Figure 19. 125I-albumin uptake by A549 cells is mediated by clathrin-mediated 
endocytosis  
(A) Subconfluent monolayers of A549 cells plated in 6-well tissue culture dishes were 
pre-incubated for 30 min either with vehicle (red), chlorpromazine (Chlorprom, blue) or 
filipin (green) or their combinations (black). The medium was then removed and 
replaced by medium containing 125I-albumin in the presence or absence of the 
inhibitors. Uptake of the radio-labeled protein was determined after 2.5, 5, 10, 30 or 60 
min from cell lysates by gamma-emission counting. Each data point represents the mean 
of at least four independent experiments. (B) 125I-albumin uptake was expressed as area 
under the curve and compared to vehicle-treated controls which were set at 100 % 
**, p < 0.01, when compared to control; ##, p < 0.01, when compared to any other 
group. 
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3.12 Albumin movement across the alveolo-capillary barrier is mediated by 
transcytosis 
 
In further experiments, phalloidin oleate, a membrane-permeable inhibitor of 
actin cytoskeletal rearrangement (Stenbeck and Horton 2004), and thus 
transcytosis, was pre-nebulized into lungs prior to aerosolization of 125I-albumin, 
to investigate whether transport of the radio-labeled protein can be altered by 
inhibition of this process. Deposition of phalloidin oleate into the ELF 
significantly decreased the active transport of the radio-labeled protein from the 
alveolar space to the vasculature of the lung (Figure 20 A and B), since the 
active transport rate of 125I-albumin was inhibited by 51.4 ± 1.2 % compared to 
control lungs that had been pre-nebulized with vehicle alone. In some additional 
experiments, monensin, another potent inhibitor of transcytosis (Sakagami, 
Byron et al. 2002), was deposited by nebulization into the air space, followed by 
aerosolization of 125I-albumin, to confirm our findings with PO. Indeed, similar 
to the effects observed with PO, 125I-albumin transport across the alveolo-
capillary barrier significantly decreased after monensin treatment, since the rate 
of active radio-labeled albumin transit was blocked by 34.0 ± 1.2 % (compared to 
control lungs; Figure 20 A and B). These data collectively suggest that 
transcytosis plays an important role in movement of albumin from the distal air 
spaces to the vasculature. 
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Figure 20. Active clearance of 125I-albumin from the alveolar space is mediated by 
transcytosis of the protein. 
(A) Control lungs were sham-nebulized with 0.1 % [vol/vol] methanol in physiological 
saline (red) 30 min after achieving steady-state. In additional experiments, lungs were 
either aerosolized with phalloidin oleate (PO, blue) or with monensin (green) instead of 
the sham-nebulization. The 125I-albumin tracer was deposited into the alveolar space 
after a further 30 min and elimination of the tracer from the lung was monitored as 
described above. Data represent the mean of six independent experiments. (B) Active 
125I-albumin transport was set at 100% in control lungs and active transport of the tracer 
in transcytosis inhibitor-treated lungs was expressed relative to this control value. Bars 
represent the mean ± SD (n = 6 for all groups); **, p < 0.01. 
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3.13 Albumin movement across the alveolo-capillary barrier involves 
albumin degradation 
 
Since inhibition of transcytosis (which by definition mediates transit of intact 
macromolecules) resulted only in a partial blockage of albumin movement across 
the air-blood barrier, it was speculated that some of the radio-labeled protein may 
be degraded during the transport process. Therefore, in further experiments, we 
assessed the amount of intact 125I-albumin in the vascular space at the end of the 
experiment by TCA precipitation. At 37 °C approximately 50 % of the radio-
labeled albumin was found to be intact (Figure 21). In contrast, in experiments 
conducted at 4 °C, ~90 % of the vascular 125I-albumin was degraded, however, 
the amount of radiation in the perfusate was only ~10 % that oberved in those 
experiments conducted at normal body temperature (Figure 21). Intactness of 
125I-albumin was also assessed by centrifugal filter fractionation in samples 
obtained the same way described above. When a centrifugal filter device with a 
molecular cut-off of 50 kDa was used, results obtained were almost identical to 
those obtained by TCA precipitation (data not shown). The potential significance 
of these findings is discussed in detail in the “Discussion” section. 
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Figure 21. 125I-albumin is partially degraded in the vascular space. 
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Intactness of 125I-albumin was assessed by TCA precipitation from perfusate samples 
from experiments conducted either at 37 °C or at 4 °C. Data are given as mean ± SD 
and represent relative values compared to total radiation of perfusate samples from 
experiments conducted at 37 °C (solid bar on the left). The solid bar on the right 
represents the total radiation of perfusate samples at 4 °C. Open bars represent free 125I 
released from degraded radio-labeled albumin. n = 6 for all groups. 
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4. Discussion 
 
 
Alveolar protein balance is an emerging area of interest in the pathogenesis of 
ARDS (Hastings, Folkesson et al. 2004). Excess alveolar albumin in particular, 
has been implicated in the pathogenesis of ARDS, and has been identified as a 
prognostic factor for this syndrome (Bachofen and Weibel 1977). Levels of 
plasma proteins are elevated in the alveolar fluids from patients with ARDS, 
contributing to the persistence of pulmonary edema and thereby impeding 
healing, and thus clearance, of the excess alveolar protein which is a key step in 
the resolution of acute lung injury (Hastings, Folkesson et al. 2004). Over the 
past decades several possible mechanisms of alveolar protein clearance have 
been studied, including mucociliary clearance, phagocytosis by macrophages, 
degradation of proteins, passive paracellular transport and active transcellular 
transport across the epithelium (Folkesson, Matthay et al. 1996; Kim and Malik 
2003; Hastings, Folkesson et al. 2004). However, despite intensive research, the 
precise mechanism by which proteins are cleared from the distal air spaces 
remains poorly understood. 
 We addressed this question in an isolated, ventilated, and perfused rabbit 
lung model. The main advantage of this intact organ model is that the 
(patho)physiology of the lung can be studied independently of the rest of the 
organism; local physiological hemostasis, physiological cell-to-cell contacts and 
cell polarity are maintained, hemodynamics are controlled, and relevant 
physiological parameters can be measured (Seeger, Walmrath et al. 1994). 
However, the lung isolation procedure requires neural dissection and perfusion 
and artificial respiration, which may alter biochemical or metabolic processes of 
the lung, thereby limiting the use of this model. Furthermore, in spite of thorough 
rinsing of the vasculature of the isolated organ, adherent leukocytes including 
monocytes, granulocytes and lymphocytes remain in the vascular bed, and their 
contribution to physiological or biochemical events is unclear and difficult to 
control. In spite of these drawbacks, however, we do not believe that they call 
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into question the validity of the conclusions we draw from our investigations, 
since all experiments were performed in lungs which exhibited virtually identical 
steady-state conditions. Thus, the isolated, ventilated and perfused rabbit lung 
model represents a powerful tool with which to investigate movement of radio-
labeled molecules (such as 125I-albumin) in real-time from the alveolar to the 
vascular compartment or vice versa. 
The complexity of the isolated lung model makes it difficult to ascribe 
physiological and biochemical events to specific cell types. Thus, to further 
confirm our hypothesis that excess albumin was taken up by the epithelium of the 
distal air spaces, experiments in cultured human alveolar epithelial A549 cells 
were performed. This cell line is a popularly-used in vitro model of type II 
alveolar epithelial cells (Foster, Oster et al. 1998). The A549 cell line exhibits 
many characteristics of alveolar type II cells, including the existence of lamellar 
inclusion bodies and the ability to synthesize surfactant constituents (Lieber, 
Smith et al. 1976). Furthermore, A549 cells were demonstrated to take up 
transferrin, a maker of receptor-mediated endocytosis, as well as cationised 
ferritin, an unspecific marker for absorption in a temperature-, time-, and 
concentration-dependent manner. This cell-line was also used as a tool to 
investigate sodium transport studies (Lazrak, Samanta et al. 2000) because of 
similarities in sodium channel expression when compared with primary alveolar 
type II cells. However, in contrast to type II cells, A549 cells neither polarize nor 
form fully-developed intercellular junctions, and are therefore unable to establish 
electrophysiologically tight monolayers (Foster, Oster et al. 1998). Consequently, 
transcytosis cannot be addressed in this cell-line. Additionally, A549 cells 
represent only one cell type of the alveolar epithelium (type II cells, which have 
been accredited with a key role in transport processes) but not type I cells. 
Nevertheless, A549 cells represent a powerful tool to with which investigate 
alveolar epithelial uptake of macromolecules such as albumin. 
All previous reports agree that mucociliary clearance and phagocytosis by 
macrophages contribute marginally to the clearance of excess protein from the air 
spaces, whereas cleavage of proteins, and passive or active transport across the 
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epithelium, might be of importance in trafficking of proteins across the alveolar 
epithelium (Hastings, Folkesson et al. 2004). We first addressed the question of 
whether excess alveolar albumin was cleared by active or passive processes, and 
whether movement of proteins through the alveolo-capillary barrier was 
vectorial. We deposited 125I-albumin into the distal air spaces of intact lungs by 
nebulization and measured movement of the radio-labeled albumin from the 
alveolar compartment to the vascular compartment in real-time using γ-detectors 
placed around the lungs and the perfusate reservoir. 
When generating particles of alveolar-accessible size, as currently done, 
aerosolization is a most powerful tool to achieve homogeneous alveolar 
deposition of any solute. When this technique was used for labeled albumin, 
controls were performed to ascertain that the protein was not fragmented and that 
the label was not dissociated from the protein by the ultrasonic device. A yield of 
~50 % of the total nebulized volume was deposited into the lung as calculated 
from the tracer measurement of lung and perfusate which compares favorably 
with data in the literature, in which deposition fractions ranging from <5 % up to 
60 % are reported (Schlesinger 1985; Ghofrani, Kohstall et al. 2001; Vadasz, 
Morty et al. 2005). The reproducibility of the aerosol technique is well reflected 
by the small variation in counts detected after tracer loading between the 
different lungs. The use of highly sensitive γ detectors, constructed to capture a 
large percentage of the lung and perfusate reservoir surfaces, allowed highly 
reproducible data with relatively low absolute tracer quantities to be obtained. 
Our data indicated that under control conditions (37 °C) approximately 
30 % of 125I-albumin deposited into the alveolar space was cleared during the 
120 min time-course of the experiment (Figure 8). The rate of albumin 
movement across the alveolo-capillary barrier was thus somewhat more rapid 
than previously reported by our group (albumin passage after 120 minutes  
~18 %) (Ghofrani, Kohstall et al. 2001) for isolated, ventilated and perfused 
rabbit lungs and rabbit lungs in vivo (albumin passage after 90 min ~12 %) 
(Verbrugge, Gommers et al. 1996). Although a recent report in which isolated, 
ventilated and perfused rat lungs were used to measure albumin transport 
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estimated that approximately 25 % of instilled radio-labeled albumin was cleared 
from the lung preparations per hour (John, Vogel et al. 2001). One possible 
explanation for this discrepancy is the different ventilation strategy applied in the 
two studies. While in our previous trial we used a PEEP of 1 mm Hg (Ghofrani, 
Kohstall et al. 2001) in the present study we applied a PEEP of 2 mm Hg to 
prevent any atelectasis, thus it is possible that an enhanced clearance rate was 
attributable to the increased surface area as consequence of the higher end-
expiratory pressure. Importantly and in line with these findings, clearance of 
radio-labeled sodium from the alveolar space also increased when the PEEP was 
elevated from 1 to 2 mmHg in the same isolated lung model (Ghofrani, Kohstall 
et al. 2001; Vadasz, Morty et al. 2005). 
However, albumin clearance rates were reported to be markedly different 
in fluid-filled lungs. Data for albumin clearance in fluid-filled lungs range from 
0.007 %/min in rats (Jayr, Garat et al. 1994), 0.02 %/min in rabbits (Hastings, 
Grady et al. 1992), and 0.06 %/min in sheep (Peterson, Dickerson et al. 1989). 
Since most work addressing transport properties in the lung was initially done in 
fluid-filled lungs, investigators initially concluded that the flux of large proteins 
like albumin through the alveolo-capillary barrier was an extremely slow process 
and reflected the intactness of the air-blood barrier (Hastings, Grady et al. 1992; 
Hastings, Wright et al. 1994; Wangensteen, Bartlett et al. 1996). The underlying 
reason for the apparent discrepancy when compared with the albumin clearance 
rates in different models is presently unknown. However, a possible explanation 
might be that the instillate applied in studies where low protein clearance rates 
were measured generally contained high levels of plasma proteins, (Hastings, 
Wright et al. 1994; Wangensteen, Bartlett et al. 1996) including native albumin, 
and it is therefore possible that these investigators characterized the fraction of 
transalveolar protein transport which was not inhibited by the excess (competing) 
unlabeled albumin. Thus, these studies probably assessed mainly passive 
transport of albumin. In contrast, when alveolar instillates contained very low 
levels of native albumin, a much more rapid transport of labeled albumin 
occurred (Ghofrani, Kohstall et al. 2001; John, Vogel et al. 2001). 
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When lungs were maintained at 22 °C or 4 °C, the clearance of albumin 
from the distal air spaces was markedly decreased (Figure 8). This was not due 
to a change in epithelial permeability since clearance of [3H]mannitol, a marker 
of passive paracellular movement of solutes and thus epithelial permeability 
(Effros, Mason et al. 1986), was unaffected by low temperature (Figure 9). 
These findings are in line with several reports suggesting that movement of 
proteins through the air-blood barrier is temperature-sensitive (Hostetter, Dawson 
et al. 1981; Serikov, Grady et al. 1993). Movement of albumin at 4 °C is 
exclusively passive, because all vesicular movement is completely shut down at 
~15 °C (Kim and Malik 2003; Hastings, Folkesson et al. 2004) and thus all active 
transport processes are fully inhibited at 4 °C (Rutschman, Olivera et al. 1993). 
Since passive transepithelial movement was unaltered under all experimental 
conditions and 125I-albumin was cleared much faster (approximately 10-fold) at 
37 °C than at 4 °C, we concluded that under control conditions (37 °C) the bulk 
of albumin clearance is probably a result of an active transport process. 
Approximately 15 % of 125I was uncoupled from albumin in the alveolar 
space. Since 125I is a small solute, it can cross the alveolo-capillary barrier via 
paracellular pathways to a similar extent as sodium (Effros, Mason et al. 1986). 
In addition to this passive diffusion, it has been well established that 125I, 
although to a much smaller extent, is transported across the alveolar epithelium 
through chloride channels, such as the cystic fibrosis transmembrane 
conductance regulator (CFTR) (Shen, Mrsny et al. 1995). Therefore, clearance of 
the free 125I might interfere with our measurements accounting for some of the 
clearance rate we assess for 125I-albumin. However, at 4 °C, when amounts of 
free 125I were identical to that of measured 37 °C (~15 %; Figure 10) the 
clearance rate of 125I-albumin was measured to be approximately 10 % of the 
control transport rate at 37 °C. In contrast, passive movement of the small solute 
[3H]mannitol was found to be unaltered at this temperature. It is important to note 
that the majority of free 125I movement through the alveolo-capillary barrier is 
also mediated by passive paracellular transport which remains intact at this 
temperature. Therefore, although the rate of the radio-labeled albumin clearance 
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from the alveolar space may be overestimated, it is unlikely that this artifact calls 
into question the validity of the conclusions we draw from our investigations. 
Measurements were always made in the presence of this small free 125I fraction 
and passive paracellular permeability, through which the vast majority of free 125I 
fraction would leave the alveolar space, was not significantly altered under any 
experimental conditions. Furthermore, transport of 125I-albumin could be 
effectively blocked by a variety of interventions, which maintained the level of 
free 125I fraction in the ELF volume equivalent to that observed in untreated 
control lungs. 
Under control conditions the perfusate of our isolated lung model does not 
contain any protein. Therefore, an albumin gradient between the alveolar 
compartment (which contains trace amounts of albumin) and vascular space may 
exist, which might promote passive movement of the albumin from the distal air 
space to the vasculature. However, in the presence of excess albumin in the 
vascular compartment, where this gradient was eliminated no change in the 
clearance of 125I-albumin from the airspaces occurred. These data further 
strengthen the hypothesis that albumin clearance from the distal airways is 
mediated by an active process (Figure 13). 
Importantly, it was also found that movement of albumin through the 
alveolo-capillary barrier was vectorial. When FITC-labeled albumin was 
administered to the vascular compartment of the lung, the transport rate from the 
vasculature to the alveolar compartment was less dependent on temperature 
(values were comparable at 37 °C and 4 °C) and were similar to the movement 
rate measured at 4 °C from the air space to the perfusate. Thus movement of 
albumin through the air-blood barrier of the lung is facilitated mainly via active 
transport in a uni-directional manner (Figure 11). These data are in line with the 
recent publication of Kim and coworkers describing a markedly faster albumin 
transport from the apical to the basolateral, than from the basolateral to the apical 
direction, in cultured rat alveolar epithelial monolayers (Kim, Matsukawa et al. 
2003). 
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 The high albumin clearance rate observed in our isolated ventilated lung 
preparation was not due to albumin tracer dissociation (Figure 10) or 
fragmentation of the protein (Figure 12). Moreover, when the protease activity 
of the ELF was inhibited by the metallo protease inhibitor EDTA or the serine 
protease inhibitor AEBSF (Gross 1995; Greenlee, Werb et al. 2007) no effect on 
125I-albumin clearance from the alveolar space was observed (Figure 12). Since 
it was found that albumin transport accross the alveolo-capillary barrier was an 
active, temperature-dependent and uni-directional process that was independent 
of albumin degradation by proteases in the ELF, it followed that intact albumin 
was probably taken up by the alveolar epithelium. Therefore, the focus was 
shifted to the identification of the mechanism by which albumin uptake by the 
alveolar epithelium occurred, and how subsequent albumin transport across the 
alveolo-capillary barrier was regulated. 
 Albumin absorption across the alveolar epithelium could be affected by 
two pathways: (1) non-specific endocytosis (macropinocytosis) or (2) receptor-
mediated endocytosis. However, it is well established that macropinocytosis 
occurs at a much lower rate than estimated for albumin transport (John, Vogel et 
al. 2001; Kim and Malik 2003). Furthermore, pinocytic uptake does not saturate 
with increasing concentrations of exogenous proteins, and is not competed by the 
presence of other macromolecules, as opposed to the saturable receptor-mediated 
endocytosis processes (Conner and Schmid 2003). To determine the route 
through which 125I-albumin was taken up by the alveolar epithelium we measured 
125I-albumin clearance from the alveolar airspaces in the presence of a 1000-fold 
molar excess of unlabeled albumin. Deposition of the excess native albumin into 
the alveolar space significantly decreased the active transport of 125I-albumin out 
of the air spaces, however, somewhat surprisingly, only about 30 % of the active 
albumin transport was inhibited (Figure 13). In contrast, when similar 
experiments were performed in cultured alveolar epithelial cells, a 1000-fold 
molar excess of unlabeled albumin resulted in an almost complete block of radio-
labeled albumin uptake (Figure 14). We believe that the somewhat less marked 
effects of excess albumin in our intact lung preparation probably resulted from 
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the inability of our aerosol delivery system to deposit the desired amount of 
albumin to the alveoli. The aerosolized albumin solution is very viscous and thus 
it is very difficult to aerosolize. Thus, it is probable that only a fraction of the 
desired amount of native albumin reached the lungs. In any case, these data 
suggest that a receptor-mediated, saturable process is involved in the uptake of 
albumin by the alveolar epithelium.  
The notion for an albumin receptor was first proposed in the endothelium, 
in which a ~60 kDa plasma membrane sialoglycoprotein (gp60) was identified 
(Schnitzer, Ulmer et al. 1990). This protein was shown to specifically bind to 
albumin (thereby promoting its uptake by endothelial cells) but not other 
macromolecules (Schnitzer 1992). In line with our findings, gp60 has recently 
been described in the alveolar epithelium and identified as an important mediator 
of albumin uptake in these cells (John, Vogel et al. 2001; Kim and Malik 2003). 
However, several other receptors for albumin have been identified including the 
multiligand, endocytic receptors cubilin and megalin (Birn and Christensen 
2006). The ~280 kDa cell surface glycoprotein, cubilin was originally isolated as 
the intrinsic factor/vitamin B12 receptor from the small intestine and was later 
found to be also highly expressed in the kidney and in epithelial cells of the yolk 
sac (Moestrup and Kozyraki 2000). Although cubilin does not contain 
transmembrane sequences it interacts with megalin which contains a short 
transmembrane sequence to mediate particulate uptake of macromolecules such 
as high-density lipoproteins (HDL) (Moestrup, Kozyraki et al. 1998). 
Importantly, cubilin and megalin were recently shown to be essential for albumin 
reabsorption from the proximal tubule of the kidney (Birn, Fyfe et al. 2000). 
Cubilin and megalin have been recently reported to be expressed in the lung, 
where they appear to mediate HDL uptake by the alveolar epithelium (Kolleck, 
Wissel et al. 2002). Thus, there are several receptors which could bind albumin 
in the alveolar space of the lung thereby promoting its uptake by the epithelium. 
Receptor-mediated endocytosis of macromolecules is carried out by 
caveolae-mediated and clathrin-dependent pathways. Both caveolin-coated 
plasmalemmal vesicles (caveolae) and clathrin-coated pits are present in alveolar 
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type I and type II cells suggesting possible uptake of proteins via these structures 
(Mostov and Cardone 1995; Kasper, Reimann et al. 1998; Campbell, Hollins et 
al. 1999; John, Vogel et al. 2001). In the present study, pretreatment of lungs 
with the caveolae-mediated endocytosis inhibitors filipin or NEM prior to 
deposition of the radio-labeled albumin into the alveolar compartment resulted in 
a partial inhibition of 125I-albumin clearance from the distal air space. This was 
not due to a change in paracellular permeability, since neither of the 
pharmacological inhibitors had any effect on passive movement of solutes (as 
assessed by [3H]mannitol flux) through the alveolo-capillary barrier. 
Unfortunately, it was not possible to directly target the alveolar epithelium with 
these pharmacological agents since both filipin and NEM alter surface tension 
thereby preventing aerosolization. For this reason, these inhibitors were applied 
to the vascular compartment of intact lungs (Figure 15). Thus, while it could be 
concluded that transit of albumin through the alveolo-capillary barrier requires 
caveolae-mediated endocytosis, it remains uncertain whether this endocytosis 
occurs in the alveolar endothelium or the epithelium. Indeed, it has been well 
demonstrated that uptake of albumin by endothelial cells is mediated by 
caveolae-dependent endocytosis (Drab, Verkade et al. 2001; Schubert, Frank et 
al. 2001; Vogel, Minshall et al. 2001; John, Vogel et al. 2003; Mehta and Malik 
2006). Similarly, it has been recently suggested that inhibition of the caveolae-
mediated endocytosis process may result in impaired albumin absorption by the 
alveolar epithelium (John, Vogel et al. 2001; Kim, Matsukawa et al. 2003). In 
line with these findings, when filipin and NEM were applied to cultured A549 
cells, a similar effect was noted as in the isolated lung setup (Figure 16). Thus, it 
appears that caveolin function is necessary for the alveolar uptake of albumin and 
it might also play a role in subsequent transport of the protein through the 
endothelium. 
Clathrin-mediated endocytosis occurs in all mammalian cells and carries 
out the continuous uptake of nutrients, including several proteins, after binding of 
the molecules to specific receptors (Conner and Schmid 2003). Coated pits are 
formed by the assembly of cytosolic coat proteins, the main assembly unit being 
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clathrin (Owen, Collins et al. 2004). Here, the effect of clathrin inhibitors, 
chlorpromazine and phenylarsine oxide, were first examined on albumin 
clearance from the distal air space. Chlorpromazine inhibits the process by 
causing the loss of coated pits from the cell surface, probably by preventing AP-2 
binding to membranes (Wang, Rothberg et al. 1993). Phenylarsine oxide inhibits 
clathrin-mediated endocytosis by reacting with sulfhydryls to form stable ring 
structures thereby preventing formation of the clathrin-coated vesicle (Visser, 
Stevanovic et al. 2004). When either of these inhibitors was deposited into the 
alveolar space of lungs by aerosolization, a significant decrease in 125I-albumin 
transport was evident, suggesting an important role for clathrin function in the 
uptake of albumin by the alveolar epithelium (Figure 17). Similarly, when 
alveolar epithelial cells were treated with these agents albumin uptake was 
markedly inhibited (Figure 18). These observations are in line with a recent 
finding, which conclusively demonstrated that clathrin-dependent endocytosis 
was required for the uptake of albumin by cultured RLE-6TN rat alveolar 
epithelial cells (Yumoto, Nishikawa et al. 2006). However, a role for clathrin-
dependent endocytosis in the clearance of proteins from the lung has not yet been 
reported. In contrast, transport of albumin through the proximal tubule of kidney 
(Caruso-Neves, Kwon et al. 2005; Birn and Christensen 2006), across the human 
placenta (Lambot, Lybaert et al. 2006) and through epithelium of the lens (Sabah, 
Schultz et al. 2007) have been recently described. 
Transport of proteins through the epithelium could be mediated by 
vectorial transport of macromolecules across cells within vesicles, termed 
transcytosis (Tuma and Hubbard 2003). Alternatively, after internalization 
proteins might be transported to lysosomes and/or proteasomes for degradation 
(Rivett 1990). During transcytosis, once the endocytosis is complete, the released 
vesicles move through the cytoplasm, presumably on prescribed ways, bypassing 
lysosomes, to the opposite cell surface, where they fuse with the target 
membrane and release albumin by exocytosis (Mehta and Malik 2006). When the 
cell-permeable actin stabilizer PO, a potent inhibitor of endo- and transcytosis, 
was applied into the alveolar space of the intact lungs, a marked block of 
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125I-albumin clearance occurred (Figure 20), confirming the hypothesis that 
endo- and/or transcytotic events were mediating protein movement across the 
alveolo-capillary barrier. Since PO alters cytoskeletal function, which is required 
for both caveolae- and clathrin-mediated endocytosis (Engqvist-Goldstein and 
Drubin 2003), it inhibits both endocytic pathways. Importantly, administration of 
PO to lungs resulted in a significantly greater inhibition of albumin transit than 
did the inhibitors of caveolae or clathrin alone. Furthermore, when A549 cells 
were treated with the combination of blockers of the caveolin and clathrin 
function, a strong additive effect of these drugs on albumin uptake was evident 
(Figure 19). These findings strengthen our hypothesis that both endocytic 
pathways are involved in the transport of albumin. 
Since vesicle movement across the cell during transcytosis requires actin, 
PO is also a potent inhibitor of transcytosis. There are several examples of 
transcytosis being responsible for transport of proteins across the epithelium and 
the endothelium. For example, maternal IgG crosses the neonatal rat intestinal 
epithelium into the blood circulation via specific Fc receptors (Rodewald and 
Kraehenbuhl 1984), transport of immunoglobulin A from the blood circulation 
across rat hepatocytes into the bile (Mullock, Jones et al. 1980), and transport of 
low-density lipoproteins across endothelial cells (Vasile, Simionescu et al. 1983). 
Transcytosis of albumin has been extensively studied in the endothelium 
(Tiruppathi, Song et al. 1997; Vogel, Minshall et al. 2001; Minshall and Malik 
2006). Although a number of studies have investigated the contribution of 
transcytosis to clearance of protein from the air spaces, (Kim and Malik 2003; 
Hastings, Folkesson et al. 2004) its significance in albumin transport remains 
uncertain.  
When lungs were treated with monensin, an inhibitor of cellular vesicular 
transport, and thus transcytosis, albumin clearance from the lung was 
significantly inhibited, confirming the notion that transcytosis is required for 
albumin removal from the alveolar space. However, the degree of inhibition with 
monensin was not as pronounced as the effect of PO on albumin transport 
(Figure 20). There are two possible explanations to this difference. First, the pre-
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incubation time with monensin in our experiments was only 30 min at the time of 
the start of the radio-labeled albumin deposition and detection. Since clearance 
measurements were performed over a two-hour time-course the lungs were 
incubated with monensin for a total of 150 min. In contrast, in some previous 
reports, a pre-incubation time of two to three hours was employed (Deffebach, 
Bryan et al. 1996; Sakagami, Byron et al. 2002), although in other studies 
monensin was applied for rather short times (10 - 60 min) (Fittschen and Henson 
1994; Miserey-Lenkei, Parnot et al. 2002). In particular in one report alveolar 
epithelial cells and rabbit lungs were treated with monensin for one hour prior to 
measuring protein transport (Hastings, Wright et al. 1994). As discussed in detail 
in the “Introduction” section, a disadvantage of the isolated, ventilated and 
perfused lung model is, that longer experiments (more than 4 h) cannot be 
performed in this setup (Seeger, Walmrath et al. 1994), thus we elected to apply 
monensin for relatively short times. Therefore it is uncertain whether monensin 
was able to exhibit its full effect in our intact lung model. Another possible 
explanation is that while PO blocks both endo- and transcytosis, monensin would 
primarily inhibit the latter process. For these reasons, it is possible that while the 
majority of albumin clearance is mediated by an initial endocytosis of albumin 
by the alveolar epithelium, not the all of the endocytosed albumin is transported 
intact through the cells. Some of the albumin may undergo modification and 
subsequent degradation.  
In line with this notion, when the intactness of radio-labeled albumin in 
the vascular space was assessed in control experiments by TCA precipitation or 
filtering the samples with a 50 kDa cut-off, approximately 50 % of the protein 
was found to be intact (Figure 21). The additional ~50 % could have been 
resulted from degradation products of 125I-albumin, if the radio-labeled protein 
was degraded after it was taken up by the epithelium and/or free 125I, which was 
already unbound in the alveolar space and diffused accross the barrier. When the 
amount of free 125I was assessed in the perfusate in experiments conducted at 
4 °C, almost 90 % of the 125I was found to be unbound in the perfusate. Since 
paracellular movement of small solutes was unaltered at this temperature (and 
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under all other experimental conditions), we believe that the amount of free 125I 
transported at low temperature (~10 %, when compared to controls; Figure 21) 
reflects the contribution of free 125I diffusion to the amount of unbound 125I 
detected in the vasculature. Taken together, these findings suggest that the 
majority of unbound 125I detected in the perfusate occurred probably as a 
consequence of degradation of the radio-labeled albumin either while the protein 
was crossing the air-blood barrier or in the perfusate. Further research is 
warranted to address this important issue. 
In summary, albumin transport through the alveolo-capillary barrier of 
intact rabbit lungs is an active, receptor-mediated and saturable process. Excess 
albumin is taken up by the alveolar epithelium by caveolae- and clathrin-
dependent endocytosis and subsequently transported to the vasculature in part 
intact via transcytosis and in part degraded by a yet unidentified mechanism. 
Several important issues remain to be elucidated, which include the 
identification of specific albumin receptors in alveolar epithelial cells, and the 
determination of cellular signaling mechanisms involved in alveolar epithelial 
protein transport. In particular, further studies are warranted to elucidate the 
regulatory mechanisms underlying alveolar epithelial transport in health and 
disease. Better understanding of these mechanisms may ultimately lead to novel 
therapeutic approaches for the treatment of ARDS. 
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6. Abstract 
 
A hallmark of acute lung injury/acute respiratory distress syndrome (ALI/ARDS) 
is the accumulation of protein-rich edema fluid in the distal airspaces, leading to 
a life-threatening impairment of alveolar gas exchange. Accumulation of serum 
proteins (such as albumin) in the alveolar space leads to an increased oncotic 
pressure, thereby preventing fluid reabsorption and resulting in worse outcome. 
Thus, excess alveolar protein must be cleared for patients with ALI/ARDS to 
survive. However, the mechanism by which protein is removed from the alveolar 
space is not fully understood. 
To investigate the mechanisms of protein transport across the alveolo-
capillary barrier, an isolated, ventilated and perfused rabbit lung model was 
employed. Additional experiments in human epithelial A549 cells were 
conducted to further evaluate the role of the alveolar epithelium in the transport 
of albumin. Radio-labeled albumin (125I-albumin) was deposited into the distal 
air spaces of isolated, ventilated and perfused rabbit lungs by ultrasonic 
nebulization, and clearance of 125I-albumin from the alveolar space was measured 
in real-time by gamma detectors placed around the lungs and around the 
perfusate reservoir. Under control conditions 29.8 ± 2.2 % of the radio-labeled 
alveolar albumin was transported (in 120 minutes) to the vascular compartment. 
Experiments conducted at 4 °C or 22 °C resulted in significantly lower albumin 
clearance (3.7 ± 0.4 or 16.2 ± 1.1 %, respectively), suggesting that the transport 
of albumin was facilitated by an active process (no changes in paracellular 
transport rates were observed). 
The transport of albumin across the alveolo-capillary barrier was saturable 
and uni-directional, since deposition of a 1000-fold molar excess of unlabeled 
albumin into the alveolar space prior to nebulization of 125I-albumin largely 
inhibited the transport of 125I-albumin to the vasculature, while administration of 
unlabeled albumin to the vascular space had no effect on albumin clearance. In 
line with these findings, administration of a 1000-fold molar excess of unlabeled 
albumin to A549 cells inhibited uptake of 125I-albumin, suggesting that albumin 
uptake by the alveolar epithelium was receptor-mediated. When lungs were 
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treated with the transcytosis inhibitor monensin or the actin stabilizer phalloidin 
oleate, transit of albumin was significantly inhibited. No degradation of protein 
occurred in the alveolar space, as assessed by measurements of intact albumin 
from broncho-alveolar lavage samples; and pre-application of protease inhibitors, 
which had no effect on albumin clearance. These data collectively suggested that 
intact 125I-albumin was transcytosed by the alveolar epithelium. 
The initial step of transcytosis is either clathrin-dependent or caveolae-
mediated. To further dissect the mechanism of albumin uptake by the alveolar 
epithelium, lungs were pretreated with the clathrin-dependent endocytosis 
inhibitors chlorpromazine or phenylarsine oxide. Inhibition of clathrin-dependent 
endocytosis resulted in a significant decrease in the albumin transport rate in 
intact lungs. Furthermore, administration of these inhibitors to A549 cells also 
decreased 125I-albumin uptake by these cells, confirming that clathrin-dependent 
endocytosis was important for albumin clearance from the alveolar compartment. 
Interestingly, administration of the caveolae-mediated endocytosis 
inhibitors, N-ethylmaleimide or filipin to the isolated lungs also resulted in a 
significant decrease in albumin clearance from the distal air spaces. Application 
of caveolae-mediated endocytosis inhibitors to A549 cells resulted in a similar 
decrease in 125I-albumin uptake. Moreover, co-administration of the clathrin and 
caveolae inhibitors had an additive effect, suggesting that both endocytic 
pathways were required for albumin uptake by the alveolar epithelium. 
Our data indicate that clearance of albumin from the distal air spaces is 
facilitated by active transcytosis across the alveolar epithelium of intact rabbit 
lungs. Both, clathrin- and caveolae-mediated endocytosis may play a role 
albumin transport from the alveolar compartment to the vascular space. Further 
understanding of these mechanisms is of clinical importance, since an inability to 
clear excess protein from the alveolar space is associated with poor outcome in 
patients with ALI/ARDS. Interfering with the protein clearance mechanisms at 
play in the lung may ultimately lead to novel therapeutic approaches for the 
treatment of this disease. 
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7. Zusammenfassung  
 
Die Entstehung einer proteinreiche Ödemflüssigkeit in den Alveolen ist eine 
Hauptkomponente im Rahmen der Erkrankung Acute Lung Injury/Acute 
Respiratory Distress Syndrome (ALI/ARDS), welche zu einer massiven 
Einschränkung des Gasaustausches führt. Der onkotische Druck im Alveolus 
steigt massiv an, hält vermehrt Wasser in den Alveolen zurück und die Situation 
verschlimmert sich weiter. Die Auflösung des Ödems und die Verminderung der 
Proteinkonzentration sind also wichtigste Punkte für das Überleben des 
Patienten, wobei die Mechanismen zur Senkung der Albuminkonzentration in 
den Alveolen nicht vollständig bekannt sind. 
In dieser Arbeit wurden die Prozesse der Albumin-Clearence aus dem 
alveolaren Raum in das Gefäßsystem unter Zuhilfenahme des Modells der 
isolierten, ventilierten und perfundierten Kaninchenlunge untersucht. Zusätzliche 
Experimente in humanen epithelialen A549 Zellen wurden parallel durchgeführt, 
um die besondere Rolle des alveolaren Epithels beim Albumintransport näher zu 
beleuchten. Durch Vernebelung wurde 125I-Albumin in die isolierten Lungen 
eingebracht und der Transport dieses Proteins von der alveolaren auf die 
vaskulare Seite mittels Gamma-Detektoren in Echtzeit gemessen, wobei diese 
sowohl um die Lunge (Abnahme der Counts während des 120 min dauernden 
Versuches) als auch um das Perfusat (Zunahme der Counts) platziert worden 
sind. In Kontrollexperimenten (37°C) wurden in 120 Minuten 29,8 ± 2,2% des 
eingebrachten 125I-Albumin aus der Lunge in das Perfusate transportiert. Bei 4°C 
(3,7 ± 0,4%) oder 22°C (16,2 ± 1,1%) Lungentemperatur verminderte sich diese 
Transportrate signifikant. Daraus folgerten wir, dass dieser Prozess aktiv 
stattfand, wobei keine veränderten passiven, parazellularen Vorgänge bei 
verschiedenen Temperaturen beobachtet wurden. 
Dieser Transportprozess war sättigbar und uni-direktional, da in die 
Alveolen eingebrachtes, 1000fach stärker konzentriertes natives Albumin, den 
Transport von 125I-Albumin ins Perfusate signifikant verminderte. Dagegen hatte 
die Administration von nativem Albumin in das Perfusat keine Wirkung auf die 
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Transportrate. Die Aufnahme von 125I-Albumin in A549 Zellen wurde massiv 
eingeschränkt, wenn kompetitiv natives Albumin beigegeben wurde, was 
gleichfalls die Theorie einer rezeptorvermittelten Aufnahme des Proteins stützt. 
Die Transportrate von 125I-Albumin in der Lunge verminderte sich 
signifikant, wenn Transzytose Inhibitoren (Phalloidin oleate oder Monensin) 
durch Vernebelung eingebracht wurden. Daraus folgte, dass 125I-Albumin 
wahrscheinlich mittels Transcytose in intaktem Zustand durch das Epithel 
geschleust wird, da Messungen aus brochoalveolaren Lavagen die Unversehrtheit 
von 125I-Albumin ergaben und vernebelte Protease Inhibitoren keine Änderungen 
der Transportrate zufolge hatten. 
Ausgangspunkt jeder Transzytose ist entweder Clathrin- oder 
Caveolae-vermittelte Endozytose. Um deren Beteiligung zu eruieren, vernebelten 
wir Inhibitoren der Clathrin-vermittelten Endozytose (Chlorpromazine oder 
Phenylarsine oxide) in die Alveolen, was zu einer signifikanten Verminderung 
der Transportrate von 125I-Albumin führte. Auch in den Zellen (monolayer) 
führte die Gabe dieser Substanzen zu deutlich geringeren Aufnahmeraten von 
Albumin. Administration von Inhibitoren der Caveolae-vermittelten Endozytose 
(NEM oder Filipin) ins Gefäßsystem führte ebenfalls zu erniedrigten 
Transportraten vom alveolaren Teil in das Perfusat. Die Verabreichung dieser 
Inhibitoren zu A549 Zellen war ebenfalls mit einem Rückgang in der 
Aufnahmerate von 125I-Albumin vergesellschaftet. Darüber hinaus führte die 
Kombination von Inhibitoren unterschiedlicher Endozytosetypen in A549 Zellen 
sogar zu noch geringeren Aufnahmeraten von 125I-Albumin in die Zellen, so dass 
wahrscheinlich beide Typen der Endozytose für den Transport von Albumin 
durch die alveolo-kapillare Barriere vonnöten sind.  
Diese Daten zeigen, dass der Transport von Albumin von der alveolaren 
Seite in das Gefäßsystem aktiv mittels Transzytose von statten geht. Beide 
Subtypen der Endozytose sind in diesen Prozess involviert. Ein weiteres 
Verstehen dieser Vorgänge ist von hoher klinischer Relevanz, da das 
Unvermögen einer adäquaten Protein-Clearence bei Patienten mit ALI/ARDS 
eng mit den Überlebenschancen dieser Erkrankung zusammenhängt. 
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